{
  "meta": {
    "title": "00041_Late_Night_Pyq_Pyt_Marathon_-_41",
    "url": "https://brainandscalpel.vercel.app/00041-late-night-pyq-pyt-marathon-41-c5ab39f6.html",
    "scrapedAt": "2025-11-29T17:24:50.271Z"
  },
  "questions": [
    {
      "id": 9934,
      "choices": [
        {
          "id": 39702,
          "text": "<p><span style=\"font-size:12pt;\">Alopecia areata</span></p>"
        },
        {
          "id": 39703,
          "text": "<p><span style=\"font-size:12pt;\">Telogen effluvium</span></p>"
        },
        {
          "id": 39704,
          "text": "<p><span style=\"font-size:12pt;\">Tinea infection</span></p>"
        },
        {
          "id": 39705,
          "text": "<p><span style=\"font-size:12pt;\">Trichotillomania</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The diagnosis for a 23-year-old patient presenting with non-scarring alopecia in the vertex region of the head, and exhibiting histological findings of hair loss with haemorrhage into the follicular areas and mild perinuclear lymphocytic infiltrate, is what?&nbsp;</span><br><span style=\"font-size:12.0pt;\">(</span>AIIMS Nov 2017)</p>",
      "unique_key": "Q7240545",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138831,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Trichotillomania</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">From the given clinical features &amp; histopathological features, diagnosis is <strong>Trichotillomania (TTM) / Trichotillosis / Hair pulling disorder.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Clinical features suggestive of Trichotillomania in the clinical vignette:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The clinical history revealing <strong>non scarring alopecia</strong> in the vertex region (<strong>Hair pulling and plucking is commonest from the scalp</strong>)</span></li><li><span style=\"font-size:12pt;\"><strong>No&nbsp;</strong>signs of <strong>inflammation</strong></span></li><li><span style=\"font-size:12pt;\">Perifollicular <strong>hemorrhage</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Diagnostic criteria for TTM include:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Recurrent pulling&nbsp;</strong>out of one’s own hair resulting in <strong>non-scarring hair loss</strong>.</span></li><li><span style=\"font-size:12pt;\">An increasing sense of <strong>tension</strong> immediately <strong>before pulling out</strong> the hair or when <strong>attempting to resist</strong> the behaviour.</span></li><li><span style=\"font-size:12pt;\"><strong>Pleasure, gratification, or relief</strong> when pulling out the hair.</span></li><li><span style=\"font-size:12pt;\">The disturbance is <strong>not</strong> better <strong>accounted</strong> for by <strong>another mental disorder</strong>.</span></li><li><span style=\"font-size:12pt;\">The disturbance provokes <strong>clinically marked distress</strong> and/or impairment in <strong>occupational, social</strong>, or other areas of <strong>functioning.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Histopathology: No / Minimal inflammation</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Peribulbar hemorrhage&nbsp;</strong>- due to <strong>trauma</strong> from <strong>plucking</strong> of hair.</span></li><li><span style=\"font-size:12pt;\">intraepithelial and perifollicular hemorrhage and intrafollicular pigment casts.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Alopecia areata:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">While it is characterized by <strong>non-scarring alopecia</strong> and can have l<strong>ymphocytic</strong> infiltrate around the hair follicles, the <strong>hemorrhage</strong> is <strong>not a typical feature.</strong></span></li><li><span style=\"font-size:12pt;\">Generally presents as <strong>well-defined patches of hair loss</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Telogen effluvium:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It manifests as a <strong>diffuse or generalized </strong>hair shedding from the <strong>entire scalp </strong>rather than localized patches.</span></li><li><span style=\"font-size:12pt;\">It's commonly due to <strong>stress</strong>, certain <strong>medications</strong>, or <strong>illnesses</strong>.</span></li><li><span style=\"font-size:12pt;\">Histopathology would not typically show hemorrhage or the specific perinuclear infiltrate described.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Tinea infection:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Tinea capitis is a fungal infection of the scalp.</span></li><li><span style=\"font-size:12pt;\">It usually presents with <strong>scaling</strong> and possibly <strong>broken-off hairs.</strong></span></li><li><span style=\"font-size:12pt;\">Histological examination would show evidence of fungal elements (<strong>hyphae and spores</strong>) rather than hemorrhage or lymphocytic infiltrate.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In a young patient with <strong>non-scarring alopecia </strong>in the <strong>vertex</strong> region and histological findings of hair loss with <strong>follicular hemorrhage </strong>and <strong>mild lymphocytic </strong>infiltrate, the diagnosis is likely <strong>Trichotillomania</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/screenshot-2023-11-27-181350.jpg\" alt=\"\" width=\"1000\" height=\"590\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of dermatology - 9<sup>th</sup> Edition Chapter 86 &amp; 89, page nos 86.17 &amp; 89.31</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Fitzpatrick’s dermatology 9<sup>th</sup> edition page no: 1695</strong></span></p>",
      "correct_choice_id": 39705,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20447,
      "choices": [
        {
          "id": 81749,
          "text": "<p><span style=\"font-size:12.0pt;\">Chancroid</span></p>"
        },
        {
          "id": 81750,
          "text": "<p><span style=\"font-size:12.0pt;\">Syphilis</span></p>"
        },
        {
          "id": 81751,
          "text": "<p><span style=\"font-size:12.0pt;\">Herpes genitalis</span></p>"
        },
        {
          "id": 81752,
          "text": "<p><span style=\"font-size:12.0pt;\">Granuloma inguinale</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young woman presents with complaints of a painless ulcer in the genital area. It is associated with non-tender inguinal lymphadenopathy. What is the most likely diagnosis? (NEET PG 2023)</span></p>",
      "unique_key": "Q8520454",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138832,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Syphilis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given scenario points out to a diagnosis of syphilis</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>ACQUIRED SYPHILIS:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mode of acquisition - <strong>Sexual</strong> transmission &amp; <strong>Blood transfusion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Stages are as follows –</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/screenshot-2024-06-19-104451.JPG\" alt=\"\" width=\"706\" height=\"204\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/screenshot-2024-06-19-104550.JPG\" alt=\"\" width=\"1000\" height=\"768\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Chancroid: In this condition both</strong> genital <strong>ulcer</strong> and inguinal <strong>lymphadenopathy</strong> are <strong>painful</strong>. It is caused by the bacterium <strong>Haemophilus ducreyi</strong>, with an incubation period of <strong>2-5 days</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture11.jpg\" alt=\"\" width=\"500\" height=\"290\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Herpes genitalis: It </strong>causes <strong>painful ulcers </strong>in the genital region and localized <strong>tender lymphadenopathy</strong>, caused by <strong>HSV 2 </strong>&gt; 1.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture12.jpg\" alt=\"\" width=\"500\" height=\"258\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Granuloma inguinale (aka donovanosis): </strong>It is caused by the bacterium <strong>Calymmatobacter / Klebsiella granulomatis</strong>. There is <strong>NO pain in Ulcer &amp; NO Lymphadenopathy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture13.jpg\" alt=\"\" width=\"500\" height=\"158\"></strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Primary syphilis (syphiLESS)</strong> is the likely diagnosis in a patient with a <strong>Painless genital ulcer</strong> and <strong>Painless inguinal lymphadenopathy</strong>, which are classic presentations of this sexually transmitted infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>References: Rooks textbook of dermatology 9<sup>th</sup> edition page no: 28.8-29, 29.13-16</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Jawetz Melnick &amp; Adelbergs Medical Microbiology 28<sup>th</sup> edition Page no 339, 341, 342</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Ananthanarayan &amp; Paniker’s Textbook of Microbiology 10<sup>th</sup> edition Page no 379-383</strong></span></p>",
      "correct_choice_id": 81750,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51491,
      "choices": [
        {
          "id": 205481,
          "text": "<p><span style=\"font-size:12.0pt;\">Tinea corporis</span></p>"
        },
        {
          "id": 205482,
          "text": "<p><span style=\"font-size:12.0pt;\">Porokeratosis</span></p>"
        },
        {
          "id": 205483,
          "text": "<p><span style=\"font-size:12.0pt;\">Pityriasis rosea</span></p>"
        },
        {
          "id": 205484,
          "text": "<p><span style=\"font-size:12.0pt;\">Urticaria</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with annular lesions on the skin. Which of the following conditions is least likely to present with annular lesions? (INICET MAY 2024)</span></p>",
      "unique_key": "Q6389559",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138833,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Urticaria</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Urticaria, commonly known as hives, is characterized by transient, well-circumscribed, erythematous, and edematous plaques that can be pruritic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/09/screenshot-2024-07-09-113934.png\" alt=\"\" width=\"300\" height=\"290\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These lesions typically appear and disappear within a few hours and do not usually form annular (ring-shaped) patterns. Urticaria can be triggered by various factors including allergens, stress, or physical stimuli, but the lesions themselves are generally not annular.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Tinea corporis</strong>: This is a dermatophyte infection that commonly presents as annular, scaly plaques with a well-defined edge and central clearing. These ring-like lesions are characteristic of tinea infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/09/screenshot-2024-07-09-114236.png\" alt=\"\" width=\"300\" height=\"243\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/09/screenshot-2024-07-09-114358.png\" alt=\"\" width=\"600\" height=\"333\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Porokeratosis</strong>: This is a disorder of keratinization that presents with annular plaques with a distinct ridge-like border. The characteristic lesion of porokeratosis is an annular plaque with a raised, ridge-like border and central atrophy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/09/screenshot-2024-07-09-114545.png\" alt=\"\" width=\"300\" height=\"200\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pityriasis rosea</strong>: This condition often begins with a single herald patch followed by the development of multiple oval, scaly lesions that may have a ring or annular appearance. The distribution is often in a Christmas-tree pattern on the back.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/09/screenshot-2024-07-09-114707.png\" alt=\"\" width=\"300\" height=\"201\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Urticaria is characterized by transient erythematous plaques that do not typically present as annular lesions, unlike conditions such as tinea corporis, porokeratosis, and pityriasis rosea.</span></p>",
      "correct_choice_id": 205484,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9680,
      "choices": [
        {
          "id": 38687,
          "text": "<p><span style=\"font-size:18px;\">Malaria</span></p>"
        },
        {
          "id": 38688,
          "text": "<p><span style=\"font-size:18px;\">Dengue</span></p>"
        },
        {
          "id": 38689,
          "text": "<p><span style=\"font-size:18px;\">Chikungunya</span></p>"
        },
        {
          "id": 38690,
          "text": "<p><span style=\"font-size:18px;\">Fixed drug eruption</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A male patient complained of bone and joint pain and was prescribed NSAIDs. After a few days, he returned with vesiculo-bullous lesions that subsequently healed, leaving a brownish discoloration on his face (particularly in the upper lip area), as shown in the image. Based on these symptoms, what is the most likely diagnosis?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/picture1.jpg\" alt=\"\" width=\"300\" height=\"282\"></span></p>",
      "unique_key": "Q6434014",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138834,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Fixed drug eruption</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The given clinical situation suggests a diagnosis of a Fixed drug eruption. <strong>Fixed drug eruption</strong> is one of the <strong>most common</strong> forms of <strong>drug induced exanthems</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">A <strong>fixed drug eruption</strong> is a known adverse <strong>drug reaction</strong> characterized by r<strong>ecurrent</strong> skin eruptions at the <strong>same location</strong> upon <strong>re-exposure</strong> to a specific drug. The <strong>vesiculo-bullous lesions</strong> followed by <strong>brownish discoloration</strong> can be seen in <strong>fixed drug eruptions</strong>, making it the most likely diagnosis given the patient's <strong>history of NSAID use.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A</strong>. <strong>Malaria</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Etiology: Caused by the <strong>Plasmodium parasite</strong>, which is transmitted to humans via the bites of infected <strong>Anopheles mosquitoes</strong>.</span></li><li><span style=\"font-size:18px;\">Clinical Features: <strong>Fever (often cyclic), chills, sweating, headaches, muscle pains, fatigue, anemia</strong>, jaundice due to hemolysis, and enlargement of the spleen.</span></li><li><span style=\"font-size:18px;\"><strong>Why it's not the likely diagnosis</strong>: Malaria does not typically cause vesico-bullous lesions or discoloration of the face.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B.</strong>&nbsp;<strong>Dengue</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Etiology: Caused by the dengue virus, which is transmitted through the bite of <strong>Aedes</strong> mosquitoes.</span></li><li><span style=\"font-size:18px;\">Clinical Features: High fever, <strong>severe headache</strong>, <strong>pain behind the eyes, joint and muscle pain, rash, and mild bleeding</strong> (e.g., nose or gum bleed, or easy bruising).</span></li><li><span style=\"font-size:18px;\"><strong>Why it's not the likely diagnosis</strong>: While dengue can cause rashes, it does not usually result in vesico-bullous lesions or leave a persistent brownish discoloration on the skin.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C.</strong>&nbsp;<strong>Chikungunya fever:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">A strong differential diagnosis is <strong>post chikungunya pigmentation</strong> (PCP) of the face seen on the <strong>nose &amp; cheeks (Chik Sign</strong>) as shown in the below image.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture2666.jpg\" alt=\"\" width=\"300\" height=\"290\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Why it's not the likely diagnosis</strong>: However, this is not the answer because there is <strong>no</strong> antecedent history of <strong>fever</strong>, <strong>myalgia</strong>, or other symptoms suggestive of chikungunya. PCP often appears as the fever subsides and may persist for about <strong>three to six months.</strong> PCP <strong>mimics melasma</strong> &amp; may be misdiagnosed If proper history is not taken.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Fixed drug eruption (FDE)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">FDE is a drug eruption distinguished by its <strong>recurrence at the same sites</strong> on <strong>re‐challenge with the same drug</strong>, hence their site on the skin is <strong>fixed</strong>, it has a <strong>short latency</strong> and is <strong>benign</strong> in nature.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">FDE typically presents <strong>30 min to 8 h</strong> after <strong>drug exposure</strong>.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Typically, FDE presents as a sharply‐defined, round or oval <strong>erythematous and edematous</strong> plaque which evolves to become dusky, violaceous and occasionally <strong>vesicular or bullous</strong>.</span></li><li><span style=\"font-size:18px;\">Classically <strong>hyperpigmentation</strong> occurs after lesions <strong>heal.</strong> Most common cause:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:18px;\"><strong>NSAIDs - On Lips</strong></span></li><li><span style=\"font-size:18px;\"><strong>Cotrimoxazole - On Genitals</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">Acute onset pigmentary changes after <strong>NSAID</strong> use point toward the diagnosis of <strong>FDE</strong>. NSAID's are one of the most common drugs causing FDE.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Ref: Rooks textbook of dermatology, 9<sup>th</sup> edition, Chapter 118 page no 118.11, 118.12</strong></span></p><p><span style=\"font-size:18px;\"><strong>Harrisons principles of internal medicine 21<sup>st</sup> edition pages 141-142, 1633</strong></span></p>",
      "correct_choice_id": 38690,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7565,
      "choices": [
        {
          "id": 30228,
          "text": "<p><span style=\"font-size:12pt;\">HPV 2</span></p>"
        },
        {
          "id": 30229,
          "text": "<p><span style=\"font-size:12pt;\">HPV 18</span></p>"
        },
        {
          "id": 30230,
          "text": "<p><span style=\"font-size:12pt;\">HPV 6</span></p>"
        },
        {
          "id": 30231,
          "text": "<p><span style=\"font-size:12pt;\">HPV 11</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient is diagnosed with multiple anogenital warts, and the biopsy reveals squamous atypia. Among the various human papillomavirus types, which ones are classified as high-risk? (NEET PG 2022)</span></p>",
      "unique_key": "Q3991885",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138835,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;B. HPV 18</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Squamous carcinoma is the most prevalent type of cancer associated with HPV infection</strong>.</span></li><li><span style=\"font-size:12pt;\">Among the various human papillomavirus types, <strong>HPV-16 and HPV-18 are considered high-risk </strong>and are frequently implicated in the development of cervical, vaginal, and vulval cancers.</span></li><li><span style=\"font-size:12pt;\">Other<strong> high-risk types </strong>include<strong> HPV-31, HPV-33, and HPV-35.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Genital warts</strong>, also known as condyloma acuminata or venereal warts, are most commonly caused by <strong>human papillomavirus 6 (HPV-6) and human papillomavirus 11 (HPV-11)</strong>. These types, referred to as <strong>low-risk</strong>, have a <strong>lower potential</strong> to lead to malignancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Genital warts are highly infectious and are commonly acquired through <strong>sexual contact</strong>, although <strong>non-sexual transmission </strong>is also <strong>possible</strong>.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/28/screenshot-2023-09-28-1250010.jpg\" alt=\"\" width=\"700\" height=\"361\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Imiquimod and podophyllotoxin</strong></span> <span style=\"font-size:12pt;\">are first-line medications prescribed for the treatment of genital warts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>IMIQUIMOD:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Imiquimod cream uses:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Actinic keratoses</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Superficial basal cell carcinoma</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Genital warts (topical immunomodulation)</strong></span><br>&nbsp;</li></ul></li><li><span style=\"font-size:12pt;\"><strong>Mechanism of action:</strong> Activates <strong>toll-like receptors 7 and 8</strong>, leading to apoptosis in macrophages, monocytes, and dendritic cells.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A HPV 2</strong>:</span></p><ul><li><span style=\"font-size:12pt;\">This type is considered low-risk and is commonly associated with <strong>common warts</strong> that affect the <strong>hands and feet</strong>, not with anogenital warts or cancer.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C &amp; D HPV 6 and HPV 11</strong>:</span></p><ul><li><span style=\"font-size:12pt;\">These are both low-risk types that are associated with about <strong>90% of genital</strong> warts but are not typically linked with cancer.</span></li><li><span style=\"font-size:12pt;\">They are known to cause benign conditions like <strong>respiratory papillomatosis</strong> as well.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>HPV 16 &amp; 18 </strong>as <strong>high-risk types </strong>associated with <strong>anogenital cancers,</strong> and recognize that <strong>HPV 2, 6, and 11 </strong>are <strong>low-risk</strong> types not typically associated with cancer.</span></li><li><span style=\"font-size:12pt;\">It’s crucial to know the distinction between low-risk and high-risk HPV types due to the <strong>differences in prognosis and management.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>High-risk types</strong> warrant more <strong>aggressive monitoring</strong> and management due to their association with <strong>malignancy.</strong></span></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>References:</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Rook's Textbook of Dermatology - 9th Edition - Volume I Chapter 25 Page no 25.43, 25.55</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Harrisons principles of internal medicine 21<sup>st</sup> edition 198</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Shaws textbook of gynaecology 16<sup>th</sup> edition 156, 157, 486</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Jawetz Melnick &amp; Adelbergs Medical Microbiology 28<sup>th</sup> edition Page no 650</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Online resources:</strong></span></p><p><a href=\"https://pubmed.ncbi.nlm.nih.gov/9434721/\"><span style=\"font-size:12pt;\"><strong><u>https://pubmed.ncbi.nlm.nih.gov/9434721/</u></strong></span></a></p><p><a href=\"https://www.ncbi.nlm.nih.gov/books/NBK321770/\"><span style=\"font-size:12.0pt;\"><strong><u>https://www.ncbi.nlm.nih.gov/books/NBK321770/</u></strong></span></a></p>",
      "correct_choice_id": 30229,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59689,
      "choices": [
        {
          "id": 238069,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1 week</span></span></span></p>"
        },
        {
          "id": 238070,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2 weeks</span></span></span></p>"
        },
        {
          "id": 238071,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3 weeks</span></span></span></p>"
        },
        {
          "id": 238072,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4 weeks</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Postherpetic neuralgia (PHN) is characterized by pain persisting beyond how many weeks after the onset of the rash? (AIIMS NOV 2016)</span></span></span></p>",
      "unique_key": "Q9668950",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138836,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Correct Answer: D. 4 weeks</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Postherpetic neuralgia (PHN) is the most common and significant neurological complication of herpes zoster (shingles). It is defined as pain that persists after the herpes zoster rash has healed, typically lasting beyond 4 weeks or 1 month from the onset of the rash. This timeframe is used to differentiate PHN from the acute pain associated with the initial herpes zoster infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option A. 1 week:</strong> Pain at this stage is still considered part of the acute phase of herpes zoster, not PHN.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option B. 2 weeks:</strong> Similar to the 1-week mark, pain persisting for 2 weeks is generally considered acute and not classified as PHN.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option C. 3 weeks:</strong> Pain lasting 3 weeks may still be considered part of the acute phase, depending on the individual case, but PHN is typically defined after 4 weeks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Postherpetic neuralgia is defined as pain that persists for more than 4 weeks after the onset of a herpes zoster rash</span></span></span></p>",
      "correct_choice_id": 238072,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23239,
      "choices": [
        {
          "id": 92920,
          "text": "<p><span style=\"font-size:12.0pt;\">Collarette scale - Christmas tree pattern - Pityriasis rosea</span></p>"
        },
        {
          "id": 92921,
          "text": "<p><span style=\"font-size:12.0pt;\">Wickham’s striae - Lichen planus</span></p>"
        },
        {
          "id": 92922,
          "text": "<p><span style=\"font-size:12.0pt;\">Christmas tree pattern - Lichen planus</span></p>"
        },
        {
          "id": 92923,
          "text": "<p><span style=\"font-size:12.0pt;\">Wornoff ring – Seborrheic dermatitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young male, aged 24, has presented with asymptomatic scaly skin lesions on his back, symmetrically distributed. The provided images showcase the lesions. Can you identify the pattern of these skin lesions &amp; the specific disease?&nbsp;</span>(INICET MAY 2023)</p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/16/whatsapp-image-2023-06-12-at-190121011010201026_page_54.jpg\" alt=\"\" width=\"400\" height=\"174\"></span></p>",
      "unique_key": "Q5485594",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138837,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Collarette scale - Christmas tree pattern - Pityriasis rosea</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given clinical scenario and images showing Collarette scale (Herald patch) and Christmas tree pattern distributed lesions, points to a diagnosis of Pityriasis rosea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>PITYRIASIS ROSEA</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Acute</strong>: <strong>Self-limiting (6-12 weeks)</strong> disease.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Etiology</strong>: Most common viral trigger is HHV 7.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Asymptomatic &gt;&gt; mild pruritus</strong> may be present.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Features</strong>:</span><ul><li><span style=\"font-size:12.0pt;\"><strong>1st lesion</strong>: Herald patch / mother patch 1-2 weeks later.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Secondary lesions</strong>: Scaly papules → oval annular plaques → mild pigmentary changes → fades slowly in 6-12 weeks.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Distribution of Lesions</strong>: Christmas tree pattern (Downwards &amp; outwards from the spine along the lines of Langer).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment</strong>: Counsel, self-limiting <strong>6-12 weeks.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B: Wickham’s striae - Lichen Planus</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Incorrect:</strong> Lichen Planus is characterized by pruritic, purple, polygonal papules and plaques. Wickham’s striae are white, lacy lines seen on the surface of lesions, typically not featuring a Christmas tree pattern.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/16/whatsapp-image-2023-06-12-at-190121011010201026_page_56.jpg\" alt=\"\" width=\"400\" height=\"287\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C: Christmas tree pattern - Lichen Planus</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Incorrect:</strong> While Lichen Planus can have a wide distribution, it does not typically display a Christmas tree pattern, which is specifically associated with Pityriasis rosea.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D: Wornoff ring – Seborrheic Dermatitis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Incorrect:</strong> Seborrheic Dermatitis typically presents with oily, scaly patches on the scalp, face, and other sebaceous areas, not as a Christmas tree pattern on the back.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The diagnosis of Pityriasis rosea is primarily based on the characteristic appearance and distribution of the rash, with the herald patch and subsequent Christmas tree pattern being hallmark features. Awareness of this pattern and the self-limiting nature of the disease helps in reassuring patients and managing expectations regarding the course of the condition</span></p>",
      "correct_choice_id": 92920,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9706,
      "choices": [
        {
          "id": 38791,
          "text": "<p><span style=\"font-size:12.0pt;\">Steroids</span></p>"
        },
        {
          "id": 38792,
          "text": "<p><span style=\"font-size:12.0pt;\">Isotretinoin</span></p>"
        },
        {
          "id": 38793,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythromycin</span></p>"
        },
        {
          "id": 38794,
          "text": "<p><span style=\"font-size:12.0pt;\">Tetracycline</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In the case of a patient presenting with multiple nodulocystic lesions on the face, which drug is considered the preferred choice for treatment?(</span>AIIMS May 2018)</p>",
      "unique_key": "Q1217771",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138838,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Isotretinoin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is a case of <strong>nodular acne.</strong> It comes under <strong>grade IV/severe acne</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Oral isotretinoin</strong>, an oral <strong>retinoid</strong> is indicated for the treatment of <strong>severe acne (nodular, acne conglobata &amp; recalcitrant acne.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Recalcitrant acne&nbsp;</strong>is <strong>poorly responsive</strong> acne, with <strong>less than 50% improvement</strong> after 6 months of therapy with <strong>combined oral &amp; topical antibiotics</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ACNE VULGARIS:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Most common form of acne.</span></li><li><span style=\"font-size:12.0pt;\">Most characteristic lesion - Comedones.</span></li><li><span style=\"font-size:12.0pt;\">Most severe form of acne vulgaris - Grade IV / Nodulocystic Acne.</span></li><li><span style=\"font-size:12.0pt;\">Most severe form of acne - Acne conglobata.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Comedones&nbsp;</strong>(are considered as <strong>special lesions</strong>) are the <strong>specific lesions</strong> of acne vulgaris</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Acne&nbsp;</strong>is a <strong>chronic inflammatory</strong> disease of the <strong>pilosebaceous unit</strong>. Comedonal lesions are the <strong>Earliest lesions</strong> of acne. They represent the keratin plugs of the pilosebaceous duct.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When the <strong>keratin plug</strong> is <strong>inside</strong> the follicle, it is called a <strong>closed</strong> comedone or <strong>whitehead</strong> .</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When the <strong>keratin plug</strong> is <strong>exposed</strong> to the environment, it gets <strong>oxidised</strong> by the air &amp; turns <strong>black</strong> which is known as <strong>open comedone (blackhead)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Stages of acne</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture65555.jpg\" alt=\"\" width=\"500\" height=\"612\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">According to <strong>Global alliance algorithm</strong> for acne, <strong>Oral isotretinoin</strong> is indicated for the treatment of severe acne.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Global alliance algorithm for acne treatment</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Image: global alliance algorithm for improving outcomes in acne</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Global alliance algorithm for acne treatment:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-13493.jpg\" alt=\"\" width=\"700\" height=\"137\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-13494.jpg\" alt=\"\" width=\"700\" height=\"353\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">BPO= Benzoyl peroxide.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong>Steroids particularly <strong>corticosteroids</strong>, can reduce inflammation and are sometimes used to treat severe <strong>inflammatory</strong> conditions. However, <strong>systemic</strong> corticosteroids are generally not a first-line treatment for nodulocystic acne because of their potential side effects, including <strong>exacerbating acne</strong> upon <strong>withdrawal.</strong> <strong>Intralesional</strong> corticosteroids can be used for <strong>large, painful</strong> nodules but are not the primary treatment for widespread nodulocystic acne.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Erythromycin: </strong>It<strong> </strong>is an antibiotic that can be used to treat acne due to its <strong>antibacteria</strong>l effects against <strong>Cutibacterium acnes</strong> (formerly <strong>Propionibacterium acnes)</strong>, the bacteria partly responsible for acne. However, it is not as effective as isotretinoin for severe nodulocystic acne and is generally used for less severe forms or when other treatments are contraindicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tetracycline:</strong> It is another class of antibiotics used in the treatment of acne. While tetracyclines can be effective for <strong>inflammatory</strong> acne, they are typically less effective than isotretinoin for severe nodulocystic acne and are not the preferred treatment in such cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>::</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Isotretinoin&nbsp;</strong>is the preferred treatment for <strong>severe nodulocystic</strong> acne due to its comprehensive action on <strong>reducing sebum</strong> production, decreasing <strong>inflammation</strong>, and <strong>normalizing keratinization</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition Volume 3 Chapter 90 page no 90.7 &amp; 90.37</strong></span></p>",
      "correct_choice_id": 38792,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9748,
      "choices": [
        {
          "id": 38959,
          "text": "<p><span style=\"font-size:12.0pt;\">All cases should receive prophylactic antibiotic</span></p>"
        },
        {
          "id": 38960,
          "text": "<p><span style=\"font-size:12.0pt;\">May lead to Pugilistic ear</span></p>"
        },
        {
          "id": 38961,
          "text": "<p><span style=\"font-size:12.0pt;\">Caused by accumulation of blood in perichondrial space</span></p>"
        },
        {
          "id": 38962,
          "text": "<p><span style=\"font-size:12.0pt;\">Resolves spontaneously</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old female came to the hospital with a history of trauma to the ear. On examination, there is swelling, tenderness, and discoloration of the ear. Which of the following is false regarding the given image? (</span>INICET May 2020)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/picture1_2rkRfWn.jpg\" alt=\"\" width=\"250\" height=\"333\"></span></p>",
      "unique_key": "Q9457055",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138840,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Resolves spontaneously</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A <strong>hematoma</strong> of the <strong>auricle</strong> is depicted in the image given.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The scenario described seems to suggest a case of <strong>auricular hematoma</strong>, which is a collection of <strong>blood</strong> in the <strong>perichondrial</strong> <strong>space</strong> of the ear, usually following <strong>trauma</strong>. Here is a breakdown of the options provided:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This statement is false regarding <strong>Perichondral hematoma</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">. If an <strong>Perichondral hematoma</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">is left untreated, it usually does not resolve spontaneously. Instead, it often requires intervention to prevent <strong>complications</strong> such as infection or the development of <strong>'Cauliflower</strong> <strong>ear'</strong>. The standard treatment involves <strong>aspiration</strong> of the <strong>hematoma</strong> or <strong>surgical</strong> intervention to prevent <strong>permanent</strong> <strong>deformity</strong> and to reestablish the connection between the <strong>cartilage</strong> and the overlying <strong>perichondrium</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. All cases should receive prophylactic antibiotic:&nbsp;</strong>While not all cases may strictly require prophylactic antibiotics, they are often <strong>administered</strong> in <strong>practice</strong> to <strong>prevent</strong> <strong>infection</strong>, especially because the <strong>ear</strong> <strong>cartilage</strong> is <strong>avascular</strong> and therefore more <strong>susceptible</strong> to <strong>infection</strong>. The effectiveness of prophylactic antibiotics is debated, but it is a common practice, particularly when there's been a <strong>break</strong> in the <strong>skin</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. May lead to Pugilistic&nbsp;ear</strong>: This is true. A <strong>'Pugilistic</strong> <strong>ear'</strong> is another term for <strong>'Cauliflower</strong> <strong>ear'</strong>, which can occur if an auricular hematoma is not adequately treated, leading to <strong>fibrosis</strong> and <strong>cartilage</strong> <strong>deformity</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Caused by accumulation of blood in perichondrial space:&nbsp;</strong>This is correct. An <strong>auricular</strong> <strong>hematoma</strong> occurs when <strong>blood</strong> accumulates in the space between the <strong>cartilage</strong> and the <strong>perichondrium</strong>, which can occur after a <strong>blunt</strong> <strong>trauma</strong> to the ear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Perichondral hematoma</strong> <strong>(cauliflower ear, wrestler's ear, or pugilistic ear):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It is a deformity of the ear brought on by <strong>repeated trauma.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Perichondral space&nbsp;</strong>refers to the area of blood between the <strong>auricular cartilage</strong> and its <strong>perichondrium.</strong></span></li><li><span style=\"font-size:12.0pt;\">Due to <strong>blunt trauma</strong>, it is frequently observed in <strong>boxers, wrestlers, and rugby</strong> players.</span></li><li><span style=\"font-size:12.0pt;\"><strong>It does not resolve spontaneously</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Treatment:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Prophylactic antibiotics</strong> should be administered in all cases.</span></li><li><span style=\"font-size:12.0pt;\">Under strict <strong>aseptic guidelines</strong>, aspiration of the hematoma and application of a pressure dressing to stop re-accumulation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Aspiration</strong> might have to be done again. Aspiration that doesn't work should be followed by incision and drainage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - </strong></span><a href=\"https://www.ncbi.nlm.nih.gov/books/NBK470424/\"><span style=\"font-size:12.0pt;\"><strong><u>https://www.ncbi.nlm.nih.gov/books/NBK470424/</u></strong></span></a><span style=\"font-size:12.0pt;\"><strong> &nbsp;&nbsp;</strong></span></p>",
      "correct_choice_id": 38962,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7456,
      "choices": [
        {
          "id": 29792,
          "text": "<p><span style=\"font-size:12pt;\">Seborrhoeic dermatitis</span></p>"
        },
        {
          "id": 29793,
          "text": "<p><span style=\"font-size:12pt;\">Atopic dermatitis</span></p>"
        },
        {
          "id": 29794,
          "text": "<p><span style=\"font-size:12pt;\">Allergic contact dermatitis</span></p>"
        },
        {
          "id": 29795,
          "text": "<p><span style=\"font-size:12pt;\">Erysipelas</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 15-year-old girl presents to the OPD. She had itchy lesions on her arm as shown with a family history of asthma. What could be the most probable diagnosis? (NEET PG 2019)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-1294.jpg\" alt=\"\" width=\"300\" height=\"240\"></p>",
      "unique_key": "Q3994123",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138841,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;B. Atopic dermatitis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The image displays <strong>scratch marks and excoriations </strong>caused by <strong>pruritic lesions </strong>at a <strong>flexural site. </strong>The patient has a personal <strong>history</strong> of <strong>chronic and recurrent course</strong>, and there is also a <strong>family history of atopy</strong>, specifically <strong>asthma</strong>. <strong>These findings suggest a diagnosis of atopic dermatitis (AD) or atopic eczema (AE).</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Atopic dermatitis (AD):</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It is a <strong>chronic inflammatory condition </strong>that tends to <strong>persist</strong> or exhibit <strong>chronic relapses.</strong></span></li><li><span style=\"font-size:12.0pt;\">In infants, the <strong>first site </strong>of involvement is often the <strong>face.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Flexural</strong> distribution is observed in both the <strong>childhood and adult</strong> phases of the condition, while in the <strong>infantile phase</strong>,<strong> extensor</strong> distribution is more typical.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Atopic eczema can be divided into <strong>3 phases:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Infantile</span></li><li><span style=\"font-size:12pt;\">Childhood</span></li><li><span style=\"font-size:12pt;\">Adult</span></li></ol><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/14/screenshot-2024-06-14-172548.png\" alt=\"\" width=\"1000\" height=\"320\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Atopic eczema infantile variant with face affected:</strong></span></p><p>&nbsp;</p><p><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/16/untitled-1296.jpg\" alt=\"\" width=\"300\" height=\"272\"></strong></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Atopic dermatitis typically presents with <strong>erythematous papules or papulovesicular</strong> lesions, often appearing in early childhood.</span></li><li><span style=\"font-size:12.0pt;\">As the condition progresses, the lesions may evolve into <strong>excoriated and lichenified</strong> areas. Atopic dermatitis is commonly associated with <strong>secondary infections</strong> and skin dryness.</span></li><li><span style=\"font-size:12.0pt;\">In the diagnosis of atopic dermatitis, the <strong>UK refinement</strong> of the <strong>Hanifin &amp; Rajka criteria</strong> is employed.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>UK refinement of Hanifin &amp; Rajka’s diagnostic criteria of atopic dermatitis (Eczema).</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">An <strong>itchy</strong> skin condition (or parental <strong>report of scratching or rubbing</strong> in a child)</span></li><li><span style=\"font-size:12pt;\">Plus<strong>, three</strong> or more of the following</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:12.0pt;\">Onset <strong>below age 2 years</strong> (not used if child is under 4 years)</span></li><li><span style=\"font-size:12.0pt;\">History of <strong>skin crease</strong> involvement (including <strong>cheeks</strong> in children under 10 years)</span></li><li><span style=\"font-size:12.0pt;\">History of a generally <strong>dry skin</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Personal history</strong> of other atopic disease (or history of any <strong>atopic disease</strong> in a first degree <strong>relative</strong> in children under 4 years)</span></li><li><span style=\"font-size:12.0pt;\">Visible <strong>flexural dermatitis</strong> (or dermatitis of <strong>cheeks/ forehead</strong> and <strong>outer limbs</strong> in children under 4 years)</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Clinical features of AD include:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Dennie-morgan fold under lower eyelid</span></li><li><span style=\"font-size:12pt;\"><strong>Allergic shiners –</strong> periorbital pigmentation</span></li><li><span style=\"font-size:12pt;\"><strong>Allergic salute</strong> – horizontal groove on dorsum of nasal bridge</span></li></ul><p style=\"text-align:center;\">&nbsp;</p><p style=\"text-align:center;\">&nbsp;</p><p style=\"text-align:center;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/16/untitled-1297.jpg\" alt=\"\" width=\"300\" height=\"275\"></p><p style=\"text-align:center;\"><strong>Fig: Dennie-morgan fold</strong></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Complications of AD:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Staphylococcus aureus</strong> is the most common organism to cause <strong>secondary infections</strong> in the lesions of atopic dermatitis.</span></li></ul><p>&nbsp;</p><p><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>Option A. Seborrheic dermatitis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"background-color:white;color:black;font-size:11pt;\">This is a chronic condition that primarily affects <strong>sebum-rich areas</strong> of the body such as the <strong>scalp, face, and central chest</strong>.</span></li><li><span style=\"background-color:white;color:black;font-size:11pt;\">It's characterized by <strong>yellowish, greasy scales </strong>and underlying <strong>erythema as </strong>shown in the image below.</span></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/1_ef9oUNS.jpg\" alt=\"\" width=\"300\" height=\"225\"></p><p>&nbsp;</p><ul><li><span style=\"background-color:white;color:black;font-size:12.0pt;\">While it can be itchy, its distribution and features are different from the description given.</span></li><li><span style=\"background-color:white;color:black;font-size:12.0pt;\">There is <strong>no direct association</strong> between s<strong>eborrheic dermatitis </strong>and a <strong>family history of asthma.</strong></span></li></ul><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>Option C. Allergic contact dermatitis:</strong></span></p><ul><li><span style=\"background-color:white;color:black;font-size:12.0pt;\">This results from direct skin contact with <strong>allergens.</strong> It's an <strong>immunological response</strong> to a substance the individual has become sensitized to.</span></li><li><span style=\"background-color:white;color:black;font-size:12.0pt;\">The lesions would be more correlated with contact to specific allergens, and it's<strong> not</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"background-color:white;color:black;font-size:12.0pt;\"><strong>typically chronic or recurrent</strong> unless there is repeated exposure to the same allergen.</span></li><li><span style=\"background-color:white;color:black;font-size:12.0pt;\">The distribution would be more in line with <strong>areas that contacted the allergen</strong>, rather than the typical<strong> </strong>flexural pattern described.</span></li></ul><p>&nbsp;</p><p><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>Option D. Erysipelas:</strong></span></p><ul><li><span style=\"background-color:white;color:black;font-size:12.0pt;\">Erysipelas is an <strong>acute bacterial</strong> skin infection, typically caused by <strong>Group A Streptococcus.</strong></span></li><li><span style=\"background-color:white;color:black;font-size:12.0pt;\">It presents as a <strong>well-demarcated, raised, erythematous, and tender skin lesion</strong>, often accompanied by <strong>systemic symptoms like fever</strong>.</span></li><li><span style=\"background-color:white;color:black;font-size:12.0pt;\">This condition is <strong>acute, not chronic or recurrent</strong> as described in the scenario.</span></li><li><span style=\"background-color:white;color:black;font-size:12.0pt;\">There's <strong>no association</strong> with a <strong>family history</strong> of asthma.</span></li></ul><p>&nbsp;</p><p><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>Atopic dermatitis </strong>is a <strong>chronic, pruritic inflammatory</strong> skin disease commonly associated with <strong>flexural distribution</strong> of eczematous lesions and a <strong>family history </strong>of atopic conditions, such as asthma.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>References:</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Rooks textbook of dermatology- 9<sup>th</sup> Edition volume 2 Chapter 41 page no 41.1, 41.2, 41.13-19</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Rooks’ textbook of dermatology- 9<sup>th</sup> Edition volume 3 Chapter 149 page no 149.21</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Online resources:</strong></span></p><p><a href=\"https://www.jaad.org/article/S0190-9622(13)01095-5/fulltext\"><span style=\"font-size:12pt;\"><strong><u>https://www.jaad.org/article/S0190-9622(13)01095-5/fulltext</u></strong></span></a></p><p><span style=\"font-size:12pt;\"><strong>Question Level – Intermediate</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Question Id-7456 Unique Key-Q3994123</strong></span></p>",
      "correct_choice_id": 29793,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9899,
      "choices": [
        {
          "id": 39562,
          "text": "<p><span style=\"font-size:12pt;\">3 and 4</span></p>"
        },
        {
          "id": 39563,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, and 3</span></p>"
        },
        {
          "id": 39564,
          "text": "<p><span style=\"font-size:12pt;\">2, 3, and 4</span></p>"
        },
        {
          "id": 39565,
          "text": "<p><span style=\"font-size:12pt;\">Only 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Among the listed causes of alopecia, which one(s) result in non-scarring alopecia? (</span>INICET May 2022)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Alopecia areata</span></li><li><span style=\"font-size:12pt;\">Telogen effluvium</span></li><li><span style=\"font-size:12pt;\">Androgenic alopecia</span></li><li><span style=\"font-size:12.0pt;\">Frontal fibrosing alopecia</span>&nbsp;</li></ol>",
      "unique_key": "Q9688420",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138842,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 1, 2, and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/screenshot-2023-11-21-190130.png\" alt=\"\" width=\"1000\" height=\"499\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Non cicatricial alopecia classification:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/screenshot-2023-11-21-190332.png\" alt=\"\" width=\"1000\" height=\"288\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option 1 - Alopecia areata:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It is a persistent <strong>autoimmune</strong> condition characterized by <strong>non</strong>-<strong>scarring</strong> hair loss patches.</span></li><li><span style=\"font-size:12pt;\">This <strong>inflammatory</strong> disease involves <strong>T cells</strong> and primarily affects individuals with genetic susceptibility, being associated with <strong>HLA DR4, DR5, DQ3</strong>.</span></li><li><span style=\"font-size:12pt;\">The condition is identifiable by <strong>\"exclamation mark hairs\"</strong> – short, fragile hairs that taper toward the base, as illustrated in the image below.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/33.jpg\" alt=\"\" width=\"300\" height=\"364\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Alopecia</strong>&nbsp;<strong>totalis</strong> refers to the complete loss of <strong>scalp</strong> <strong>hair</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Alopecia</strong>&nbsp;<strong>universalis</strong> involves the loss of <strong>all</strong> <strong>body</strong> <strong>hair</strong>.</span></li><li><span style=\"font-size:12pt;\">In instances of <strong>limited</strong> alopecia areata, approximately <strong>80</strong>% of patients experience <strong>spontaneous</strong> <strong>remission</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Alopecia</strong>&nbsp;<strong>areata</strong> predominantly affects <strong>pigmented</strong> hair.</span></li><li><span style=\"font-size:12pt;\">In <strong>older</strong> individuals, <strong>gray</strong> <strong>hair</strong> may consist of both white and colored hair. If the disease <strong>progresses</strong> <strong>rapidly</strong>, only the colored hair will be affected and lost, leaving the <strong>white</strong> <strong>hair</strong> <strong>unaffected </strong>in<strong> </strong>the<strong> patches </strong>of<strong> hair loss</strong>.</span></li><li><span style=\"font-size:12pt;\">This sudden change in hair color is known as <strong>\"Turning white overnight\".</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The following image depicts sparing of white hair within patches of hair loss.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/15/screenshot-2024-06-15-145444.png\" alt=\"\" width=\"300\" height=\"239\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Fig: Alopecia areata \" Turning white overnight\"</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option 2 - Telogen effluvium:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It is <strong>an acute onset of scalp hair loss</strong> that starts one to two months after a <strong>trigger</strong>, such as a <strong>high</strong> <strong>fever</strong>, <strong>infections</strong> (Cholera, Typhoid, <strong>Covid</strong>), trauma from <strong>surgery</strong> or other trauma, <strong>starvation</strong>, <strong>MI</strong>, <strong>Pregnancy</strong>, or <strong>hemorrhage</strong>.</span></li><li><span style=\"font-size:12pt;\">It refers to an increase in the <strong>shedding</strong> of <strong>telogen</strong> club hairs due to <strong>premature</strong> <strong>termination</strong> of <strong>anagen</strong> proliferative phase of the hair cycle following a <strong>period of stress.</strong></span></li><li><span style=\"font-size:12pt;\">Telogen hair shedding that lasts <strong>longer</strong> than <strong>six</strong> <strong>months</strong> is known as <strong>chronic</strong> <strong>diffuse</strong> telogen hair loss.</span></li><li><span style=\"font-size:12pt;\"><strong>Thyroid conditions (both hyper- and hypothyroidism), severe iron deficiency Anemia, acrodermatitis enteropathica, and malnutrition</strong> are the main causes of chronic diffuse telogen hair loss.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option 3 - Androgenetic Alopecia</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The disorder known as androgenetic alopecia is characterized by the <strong>miniaturization &amp; reduction of hair follicle production</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Male&nbsp;</strong>pattern <strong>hair</strong> <strong>loss</strong> and <strong>female</strong> <strong>pattern</strong> hair loss are the two types.</span></li><li><span style=\"font-size:12pt;\"><strong>Recession&nbsp;</strong>of the <strong>frontal</strong> <strong>hairline</strong> and <strong>vertex</strong> thinning are seen in <strong>male</strong> pattern hair loss.</span></li><li><span style=\"font-size:12pt;\"><strong>Females&nbsp;</strong>may experience <strong>male</strong> <strong>pattern</strong> hair loss, and the <strong>opposite</strong> is also <strong>true.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/15/screenshot-2024-06-15-145750.png\" alt=\"\" width=\"1000\" height=\"452\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option 4 - Frontal fibrosing alopecia</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Frontal&nbsp;</strong>fibrosing alopecia is a scalp condition that affects <strong>post</strong>-<strong>menopausal</strong> <strong>women</strong> in particular and frequently involves the <strong>eyebrows</strong>.</span></li><li><span style=\"font-size:12pt;\">It is a type of <strong>primary cicatricial (scarring) alopecia</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational</strong> <strong>Objective</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Non-scarring alopecia’s</strong> do not destroy the hair follicle and allow for the possibility of hair regrowth.</span></li><li><span style=\"font-size:12pt;\"><strong>Scarring alopecia’s</strong> involve destruction and replacement of the hair follicle with scar tissue, leading to permanent hair loss.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition Chapter 89 page no 89.25, 28, 33</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Fitzpatrick’s dermatology 9<sup>th</sup> edition page 1509</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Online resource:&nbsp;</strong></span><a href=\"https://www.bmj.com/content/347/bmj.f6112\"><span style=\"font-size:12pt;\"><strong><u>https://www.bmj.com/content/347/bmj.f6112</u></strong></span></a></p>",
      "correct_choice_id": 39563,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9943,
      "choices": [
        {
          "id": 39738,
          "text": "<p><span style=\"font-size:12pt;\">Cobalt</span></p>"
        },
        {
          "id": 39739,
          "text": "<p><span style=\"font-size:12pt;\">Nickel</span></p>"
        },
        {
          "id": 39740,
          "text": "<p><span style=\"font-size:12pt;\">Iron</span></p>"
        },
        {
          "id": 39741,
          "text": "<p><span style=\"font-size:12pt;\">Chromate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which component of cement causes allergic contact dermatitis among construction workers in India? (</span>AIIMS Nov 2018)</p>",
      "unique_key": "Q8302555",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138843,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Chromate</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>It is&nbsp;</strong>a component of <strong>chromium</strong>, is commonly used in the manufacturing of cement and is a well-known cause of <strong>allergic contact dermatitis (ACD)</strong> among <strong>construction workers</strong> due to their frequent and prolonged exposure to wet cement.</span></li><li><span style=\"font-size:12pt;\">Chromate can cause ACD through a <strong>type IV delayed hypersensitivity reaction</strong>.</span></li><li><span style=\"font-size:12pt;\">When cement containing chromate comes into contact with the skin, particularly in the presence of <strong>moisture</strong>, the chromate can leach out and result in <strong>sensitization</strong> and subsequent <strong>dermatitis.</strong></span></li><li><span style=\"font-size:12pt;\">Allergic contact dermatitis is an <strong>inflammatory response</strong> to an allergen that only manifests as an eruption in people who have already been <strong>sensitized</strong> to the allergen.</span></li><li><span style=\"font-size:12pt;\">The diagnosis of ACD is made by <strong>Patch test</strong> with the culprit substances.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Cobalt:&nbsp;</strong>Cobalt is less commonly a cause of ACD in construction workers compared to chromate. Cobalt may be present in <strong>tools or dyes</strong>, but not typically in cement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Nickel:&nbsp;</strong>Nickel is a well-known cause of ACD, often associated with exposure to nickel-containing <strong>jewellery or clothing items</strong>, not with cement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;<strong>Iron:&nbsp;</strong>Iron, while common in <strong>construction</strong> materials, is <strong>not a frequent cause of ACD</strong>. It is not known to be an allergen that would typically induce contact dermatitis.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture20.jpg\" alt=\"\" width=\"400\" height=\"221\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture21.jpg\" alt=\"\" width=\"400\" height=\"221\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture22.jpg\" alt=\"\" width=\"400\" height=\"197\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture23.jpg\" alt=\"\" width=\"400\" height=\"218\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture24.jpg\" alt=\"\" width=\"400\" height=\"305\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Among <strong>construction workers</strong> in India, <strong>allergic contact dermatitis</strong> is most commonly caused by <strong>chromate</strong> in <strong>cement</strong>, due to a <strong>type IV hypersensitivity</strong> reaction when chromate comes into contact with the skin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/17/screenshot-2024-06-17-102211.png\" alt=\"\" width=\"1000\" height=\"539\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition Chapter 128 page no 128.2-14</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Online source: </strong></span><a href=\"https://europepmc.org/article/pmc/2965911\"><span style=\"font-size:12pt;\"><strong><u>https://europepmc.org/article/pmc/2965911</u></strong></span></a></p>",
      "correct_choice_id": 39741,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10226,
      "choices": [
        {
          "id": 40870,
          "text": "<p><span style=\"font-size:12pt;\">Stop MDT and start oral steroids</span></p>"
        },
        {
          "id": 40871,
          "text": "<p><span style=\"font-size:12pt;\">Antibiotics</span></p>"
        },
        {
          "id": 40872,
          "text": "<p><span style=\"font-size:12pt;\">Thalidomide</span></p>"
        },
        {
          "id": 40873,
          "text": "<p><span style=\"font-size:12pt;\">Continue MDT and add oral steroids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a pregnant woman at 12 weeks of gestation, who is currently undergoing multidrug therapy (MDT) for leprosy, she now presents with type 2 lepra reaction. What is the preferred treatment for this patient?&nbsp;</span>&nbsp;(INICET NOVEMBER 2022)</p>",
      "unique_key": "Q7376877",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138844,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. Continue MDT and add oral steroids</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">To manage a <strong>pregnant woman </strong>experiencing a <strong>type 2 lepra reaction</strong>, it is essential to <strong>continue the multidrug therapy (MDT)</strong> while adding <strong>oral steroids </strong>as an <strong>additional</strong> treatment.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">In the management of leprosy, it is crucial to <strong>continue </strong>multidrug therapy <strong>(MDT) </strong>to effectively treat the <strong>underlying infection </strong>caused by <strong>Mycobacterium leprae.</strong></span></li><li><span style=\"font-size:12pt;\">A <strong>Type 2 lepra </strong>reaction, also known as <strong>erythema nodosum leprosum (ENL), </strong>is a complex <strong>immunological reaction </strong>that occurs in <strong>lepromatous and borderline lepromatous leprosy</strong>, which can present with <strong>painful nodules</strong>, <strong>fever, malaise</strong>, and other <strong>systemic </strong>symptoms.</span></li><li><span style=\"font-size:12pt;\"><strong>Oral steroids</strong>, such as <strong>prednisone</strong>, are the treatment of choice for controlling <strong>acute inflammatory complications </strong>associated with Type 2 lepra reaction. They help <strong>reduce inflammation </strong>and <strong>immune</strong> response.</span></li><li><span style=\"font-size:12pt;\">It is important to manage the reaction <strong>without discontinuing </strong>the <strong>MDT</strong> to <strong>prevent </strong>the development of <strong>drug resistance </strong>and further progression of the disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Erythema nodosum leprosum (ENL)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It is a <strong>type 3 hypersensitive immune complex-mediated reaction</strong> that affects the <strong>skin, nerves, and other organs.</strong></span></li><li><span style=\"font-size:12pt;\">It is typically r<strong>ecurrent</strong> and commonly observed in individuals with <strong>multibacillary</strong> leprosy. ENL may occur <strong>before treatment</strong>, <strong>during treatment</strong> or <strong>after</strong> completion of treatment.</span></li><li><span style=\"font-size:12pt;\">It is characterized by <strong>painful, erythematous nodules</strong> appearing on the extensor surfaces of the <strong>limbs and face.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In a type 2 lepra reaction, <strong>systemic symptoms </strong>such as <strong>iritis, orchitis</strong>, and the appearance of <strong>fresh </strong>skin lesions can be observed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Treatment includes:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">High doses of <strong>glucocorticoids</strong> are frequently administered to all patients which assist in <strong>reducing</strong> the acute signs and symptoms of <strong>inflammation.</strong></span></li><li><span style=\"font-size:12pt;\">In patients with lepra reactions, <strong>MDT is never discontinued</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Only severe cases of type-2 lepra reaction or erythema nodosum Leprosum are treated with thalidomide.&nbsp;</strong>Thalidomide is <strong>gold standard for type II Lepra</strong> reaction, but it is <strong>NOT the Drug of Choice</strong> due to its <strong>cost</strong> factor &amp; also its <strong>Adverse drug reactions profile.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Type I &amp; II lepra reactions (ENL= Erythema Nodosum Leprosum):</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-175436.png\" alt=\"\" width=\"900\" height=\"339\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Stop MDT and start oral steroids: </strong>Stopping MDT is <strong>not advisable</strong> because it can lead to the <strong>proliferation</strong> of <strong>Mycobacterium leprae</strong> and risk the development of <strong>drug resistance.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Antibiotics: </strong>While <strong>antibiotics</strong> are a <strong>part of MDT</strong> to treat the <strong>bacterial infection</strong>, they alone are <strong>not sufficient</strong> to address the <strong>acute inflammatory symptoms</strong> of a Type 2 lepra reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Thalidomide:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Thalidomide is an effective treatment for Type 2 lepra reactions due to its potent anti-inflammatory properties.</span></li><li><span style=\"font-size:12pt;\">However, it is <strong>absolutely contraindicated</strong> in <strong>pregnant</strong> women due to its <strong>teratogenic effects</strong>, which can cause <strong>severe birth defects as seen in the below image</strong>.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-175555.png\" alt=\"\" width=\"500\" height=\"618\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Phocomelia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">In a pregnant woman with leprosy who presents with a <strong>Type 2 lepra</strong> reaction, the preferred treatment is to <strong>continue multidrug therapy</strong> and <strong>add oral steroids</strong> to manage the <strong>acute inflammatory symptoms</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Thalidomide&nbsp;</strong>is c<strong>ontraindicated</strong> in pregnancy due to its <strong>teratogenicity.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rook's Textbook of Dermatology -9th Edition Chapter 28 Page no 28.16</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Harrison’s principles of internal medicine 21<sup>st</sup> edition page no 1387, 1390</strong></span></p>",
      "correct_choice_id": 40873,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59690,
      "choices": [
        {
          "id": 238073,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Scleredema is commonly associated with diabetes mellitus and affects the neck and upper back.</span></span></span></p>"
        },
        {
          "id": 238074,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Scleredema presents with thickened, non-pitting induration of the skin without involvement of the hands and feet.</span></span></span></p>"
        },
        {
          "id": 238075,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Scleredema is associated with sclerodactyly and Raynaud&rsquo;s phenomenon.</span></span></span></p>"
        },
        {
          "id": 238076,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Scleredema results in an expanded dermis due to increased mucin deposition and thick collagen fibers.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which statement is false regarding scleredema?</span></span></span></p>",
      "unique_key": "Q6679138",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138845,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Scleredema is associated with sclerodactyly and Raynaud&rsquo;s phenomenon.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Scleredema and scleroderma are distinct conditions, and scleredema is not associated with features like sclerodactyly, Raynaud&rsquo;s phenomenon, nail fold capillary changes, or serum autoantibodies, which are characteristic of scleroderma. Scleredema primarily affects the skin on the upper back and neck, sparing the hands and feet. It involves increased mucin deposition and thickened collagen fibers without fibroblast proliferation. The most common form of scleredema is associated with diabetes mellitus, particularly in men, due to abnormal collagen synthesis and resistance to degradation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> A. Scleredema is commonly associated with diabetes mellitus and affects the neck and upper back.</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This statement is true. Scleredema is frequently associated with diabetes, particularly in men, and primarily involves the neck and upper back regions, leading to skin tightening and thickening.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> B. Scleredema presents with thickened, non-pitting induration of the skin without involvement of the hands and feet.</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is correct. Scleredema characteristically spares the hands and feet, and it presents with non-pitting induration mainly on the back and neck.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> D. Scleredema results in an expanded dermis due to increased mucin deposition and thick collagen fibers.</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is also true. Scleredema is marked by thickening of the dermis caused by mucin deposition and coarse collagen fibers, which distinguish it from other skin conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Scleredema is a condition characterized by thickened, taut skin predominantly affecting the upper back and neck, often associated with diabetes. It is distinct from scleroderma, as it lacks features such as sclerodactyly and Raynaud&rsquo;s phenomenon. Understanding the differences between these </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/03/picture4.jpg\" style=\"height:1116px; width:1000px\" /></span></span></span></p>",
      "correct_choice_id": 238075,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7489,
      "choices": [
        {
          "id": 29924,
          "text": "<p><span style=\"font-size:12pt;\">Phrynoderma</span></p>"
        },
        {
          "id": 29925,
          "text": "<p><span style=\"font-size:12pt;\">Keratoses pilaris</span></p>"
        },
        {
          "id": 29926,
          "text": "<p><span style=\"font-size:12pt;\">Darier disease</span></p>"
        },
        {
          "id": 29927,
          "text": "<p><span style=\"font-size:12pt;\">Follicular eczema</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A child with a history of night-blindness presented to you with the following findings. What is the diagnosis? (</span>NEET PG 2021)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/457.jpg\" alt=\"\" width=\"300\" height=\"392\"></span></p>",
      "unique_key": "Q2363816",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138906,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;A. Phrynoderma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">The clinical presentation of a child with <strong>night blindness and multiple hyperkeratotic papules on the elbows</strong>, as depicted in the image, raises suspicion of a diagnosis called <strong>phrynoderma or toad-skin.</strong> This condition is often linked to a <strong>deficiency of vitamin A</strong> (VAD).</span></li><li><span style=\"font-size:12.0pt;\">It is characterized by the development of <strong>keratotic follicular papules</strong>, <strong>initially appearing on the anterolateral thighs and posterolateral upper arms</strong>, and subsequently spreading to the extensor surfaces of the extremities, shoulders, abdomen, back, buttocks, face, and posterior neck.</span></li><li><span style=\"font-size:12.0pt;\">While originally reported in association with vitamin A deficiency, phrynoderma is a non-specific finding that can also be observed in deficiencies of <strong>B-complex </strong>vitamins, <strong>vitamin C</strong>, <strong>vitamin E</strong>, <strong>essential fatty acids (EFA deficiency</strong>), <strong>protein-energy malnutrition (PEM</strong>), and general states of malnutrition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Keratosis pilaris:</strong></span></p><ul><li><span style=\"font-size:12pt;\">Description: Keratosis pilaris is a common, <strong>benign</strong> skin condition that manifests as <strong>tiny, rough-feeling bumps on the skin</strong>, often likened to <strong>\"chicken skin.\"</strong> It frequently occurs on the <strong>upper arms, thighs, or cheeks.</strong></span></li><li><span style=\"font-size:12pt;\">It usually presents during puberty. Perifollicular erythema in addition to follicular plugging</span></li><li><span style=\"font-size:12pt;\">Favors the upper outer arms and the thighs, but <strong>lacks discrete clusters</strong>. Treatment is purely reserved for cosmetic purposes.</span></li><li><span style=\"font-size:12pt;\"><strong>Reason for exclusion from the diagnosis</strong>:&nbsp; While keratosis pilaris can appear on the upper arms close to the elbows, it's <strong>not</strong> specifically associated with <strong>night-blindness or vitamin A deficiency.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Darier disease:</strong></span></p><ul><li><span style=\"font-size:12pt;\">Description: Darier disease is a <strong><u>rare, genetic</u></strong> skin disorder characterized by small, <strong><u>hard bumps</u></strong> on the skin, especially on the <strong><u>chest, back, and forehead</u></strong>. These may be <strong><u>yellowish in color and often have a foul odor</u></strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Reason for exclusion from the diagnosis</strong> While Darier disease causes papules, it is not associated with night-blindness. Other features of Darier disease are also not mentioned in the question.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Follicular eczema:</strong></span></p><ul><li><span style=\"font-size:12pt;\">Description: This is a variant of <strong>eczema </strong>(atopic dermatitis) that specifically affects the hair follicles, leading to <strong>itchy, inflamed skin.</strong></span></li><li><span style=\"font-size:12pt;\">Reasons it might not fit: Though follicular eczema can cause papules, the <strong>association </strong>with <strong>night-blindness is not seen</strong>. Eczema would typically be associated with <strong>itching</strong> and possibly a history of allergies or atopy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For medical students preparing for residency, it is crucial to associate the findings of <strong>follicular hyperkeratotic</strong> papules, especially when coupled with <strong>systemic</strong> symptoms such as <strong>night-blindness</strong>, with <strong>phrynoderma</strong>, a condition related to <strong>vitamin A deficiency.</strong></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference:&nbsp; Rook's Textbook of Dermatology 9th Edition Page no 63.8</strong></span></p>",
      "correct_choice_id": 29924,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9817,
      "choices": [
        {
          "id": 39235,
          "text": "<p><span style=\"font-size:12pt;\">Bullous pemphigoid</span></p>"
        },
        {
          "id": 39236,
          "text": "<p><span style=\"font-size:12pt;\">Pemphigus vulgaris</span></p>"
        },
        {
          "id": 39237,
          "text": "<p><span style=\"font-size:12pt;\">Dermatitis herpetiformis</span></p>"
        },
        {
          "id": 39238,
          "text": "<p><span style=\"font-size:12pt;\">Linear IgA dermatosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old guy arrives with tense, itchy bullae over his limbs. The roof of the bullae collapsed after a few days. What is the most likely diagnosis shown in the clinical image below? (</span>INICET May 2021)</p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/21/picture1100.jpg\" alt=\"\" width=\"300\" height=\"203\"></span></p>",
      "unique_key": "Q6872980",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138907,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Bullous pemphigoid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given clinical scenario is highly suggestive of <strong>bullous pemphigoid.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Elderly aged</strong> people are usually affected.</span></li><li><span style=\"font-size:12pt;\">It presents as <strong>tense itchy bulla</strong>, which do <strong>not rupture easily</strong>, which can have an <strong>erythematous</strong> base (<strong>urticarial wheals</strong>) &amp; the <strong>roof</strong> of the bullae <strong>collapses</strong> after a few days forming <strong>settled bulla</strong>, autoantibodies <strong>(IgG) </strong>against <strong>BP180 (BPAG2</strong>) and <strong>BP 230 (BPAG1</strong>) antigens on <strong>hemidesmosomes</strong> are seen in these patients.</span></li><li><span style=\"font-size:12pt;\">It is a <strong>subepidermal</strong> blistering disorder, so <strong>acantholysis</strong> will <strong>not</strong> be seen.</span></li><li><span style=\"font-size:12pt;\"><strong>Histopathology:&nbsp;</strong>subepidermal bullae with <strong>eosinophils</strong></span></li><li><span style=\"font-size:12pt;\"><strong>DIF:&nbsp;</strong>deposition of IgG antibodies at the dermo-epidermal junction in a <strong>linear pattern.</strong></span></li><li><span style=\"font-size:12pt;\">It is mainly treated with <strong>Topical corticosteroids.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B</strong>. <strong>Pemphigus vulgaris</strong>: This is another <strong>autoimmune</strong> <strong>blistering</strong> <strong>disorder</strong>. However, the blisters in pemphigus vulgaris are <strong>flaccid a</strong>nd <strong>easily ruptured </strong>as shown in the image below, as opposed to the tense bullae seen in bullous pemphigoid. Additionally, the <strong>oral mucosa</strong> is frequently <strong>involved</strong> in <strong>pemphigus vulgaris</strong>.</span></p><p>&nbsp;</p><p><span style=\"color:#374151;font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/21/picture1222.jpg\" alt=\"\" width=\"300\" height=\"252\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;<strong>Dermatitis herpetiformis</strong>: This condition is associated with <strong>gluten-sensitive enteropathy (celiac disease)</strong> and presents with <strong>itchy papules, vesicles</strong>, and bullae. However, the distribution is typically on <strong>extensor</strong> surfaces like <strong>elbows and knees </strong>as shown in the image below, and the appearance differs from what is shown in the image in the MCQ.</span></p><p>&nbsp;</p><p><span style=\"color:#374151;font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/21/picture13555.jpg\" alt=\"\" width=\"500\" height=\"197\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>Linear IgA dermatosis</strong>: This is a rare autoimmune blistering disorder. The blisters are typically in a <strong>\"string of pearls</strong>\" or <strong>annular arrangement </strong>as shown in the image below.</span></p><p>&nbsp;</p><p><span style=\"color:#374151;font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/21/picture14999.jpg\" alt=\"\" width=\"200\" height=\"358\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">\"<strong>Bullous Pemphigoid</strong> is a <strong>subepidermal blistering disorder </strong>predominantly affecting the <strong>elderly</strong>, characterized by <strong>tense itchy bullae</strong>, <strong>autoantibodies</strong> against <strong>BP180 and BP230</strong>, and <strong>eosinophilic</strong> involvement.\"</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition Chapter 50, Page no. 50.4-50.37.</strong></span></p>",
      "correct_choice_id": 39235,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9724,
      "choices": [
        {
          "id": 38863,
          "text": "<p><span style=\"font-size:12.0pt;\">24 hours</span></p>"
        },
        {
          "id": 38864,
          "text": "<p><span style=\"font-size:12.0pt;\">72 hours</span></p>"
        },
        {
          "id": 38865,
          "text": "<p><span style=\"font-size:12.0pt;\">48 hours</span></p>"
        },
        {
          "id": 38866,
          "text": "<p><span style=\"font-size:12.0pt;\">96 hours</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">After administering the patch test to a 10-year-old boy with a history of allergic contact dermatitis, when should you schedule his return for patch removal? (</span>AIIMS May 2019)</p>",
      "unique_key": "Q9240628",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138908,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 48 hours</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>Gold standard</strong> Diagnostic test for <strong>Airborne contact dermatitis (ABCD</strong>) &amp; <strong>Allergic Contact Dermatitis (ACD)</strong> is a <strong>patch test.&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patch testing:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It is a method used to determine if a specific <strong>substance</strong> causes <strong>allergic</strong> inflammation of a patient's skin.</span></li><li><span style=\"font-size:12.0pt;\">It is typically indicated for patients with <strong>suspected allergic contact dermatitis</strong>.</span></li><li><span style=\"font-size:12.0pt;\">The test involves the application of various substances in small chambers or patches to the skin, usually on the <strong>back.</strong></span></li><li><span style=\"font-size:12.0pt;\">After the application of a patch test, the patches are generally <strong>removed at 48 hours (2 days),</strong> and an <strong>initial reading</strong> is taken.</span></li><li><span style=\"font-size:12.0pt;\">This timeframe allows for the elicitation of a <strong>Type IV</strong> or <strong>delayed-type hypersensitivity</strong> reaction, which is the basis of allergic contact dermatitis.</span></li><li><span style=\"font-size:12.0pt;\">However, readings at 48 hours may not be sufficient to detect all reactions, and thus an additional reading at <strong>96 hours</strong> is often recommended.</span></li><li><span style=\"font-size:12.0pt;\">The additional reading helps to identify <strong>late reactions</strong>, which could otherwise be missed if only the 48-hour reading is considered.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 24 hours</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">This timeframe is <strong>too short</strong> for most delayed-type hypersensitivity reactions to occur.</span></li><li><span style=\"font-size:12.0pt;\">Removing the patches at 24 hours would likely result in <strong>missing many positive reactions</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 72 hours</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It is not typically when the patches are first removed.</span></li><li><span style=\"font-size:12.0pt;\">The patches are usually removed at <strong>48 hours</strong>, and the skin is then <strong>inspected</strong> for any reactions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 96 hours</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">This is a common time for a <strong>follow-up reading</strong> and <strong>not</strong> the <strong>initial removal</strong> of the patches.</span></li><li><span style=\"font-size:12.0pt;\">Some protocols suggest readings at this time to ensure that late-appearing reactions are not missed.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The image below shows a patch test:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/21/picture12222.jpg\" alt=\"\" width=\"300\" height=\"225\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/screenshot-2024-06-19-102824.png\" alt=\"\" width=\"1000\" height=\"345\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref- Rooks textbook of dermatology - 9<sup>th</sup> Edition volume I Chapter 4 page no 4.23</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Fitzpatrick’s dermatology 9<sup>th</sup> edition page no 406</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Online resources: </strong></span><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900336/\"><span style=\"font-size:12.0pt;\"><strong><u>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900336/</u></strong></span></a></p>",
      "correct_choice_id": 38865,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10213,
      "choices": [
        {
          "id": 40818,
          "text": "<p><span style=\"font-size:12pt;\">Tzanck cells</span></p>"
        },
        {
          "id": 40819,
          "text": "<p><span style=\"font-size:12pt;\">Multinucleate giant cells (MNGCs)</span></p>"
        },
        {
          "id": 40820,
          "text": "<p><span style=\"font-size:12pt;\">Both A &amp; B</span></p>"
        },
        {
          "id": 40821,
          "text": "<p><span style=\"font-size:12pt;\">Henderson Patterson bodies</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with following lesions on the genitals. Scrapings from the lesion would show? (</span>INICET Nov 2021)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/2_ba9b5kJ.jpg\" alt=\"\" width=\"300\" height=\"219\"></span></p>",
      "unique_key": "Q9323469",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138909,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;C) Both A &amp; B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Tzanck cells &amp; MNGCs can be seen in Herpes lesions.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The provided image displays <strong>clusters of vesicles</strong> on an <strong>erythematous base</strong>, indicative of a possible diagnosis of <strong>genital herpes </strong>caused by <strong>Herpes simplex virus (HSV) infection.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Tzanck smear:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">To perform a Tzanck smear, scrapings are obtained from the lesions, preferably from the <strong>base of the vesicles</strong>.</span></li><li><span style=\"font-size:12pt;\">Smears are then prepared and stained with a 1% aqueous solution of <strong>O-toluidine blue</strong> for 15 seconds, which allows the visualization of <strong>acantholytic</strong> and <strong>multinucleated giant cells.</strong></span></li><li><span style=\"font-size:12pt;\">In <strong>Herpes</strong> infections, <strong>Tzanck smear</strong> examination may reveal the presence of <strong>Tzanck cells</strong> and <strong>multinucleated giant cells.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Below image depicts Acantholytic cells</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/3_dWwqGqk.jpg\" alt=\"\" width=\"500\" height=\"289\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Below image depicts multinucleated giant cells</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/4_LZvYmJE.jpg\" alt=\"\" width=\"500\" height=\"333\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Tzanck or Acantholytic&nbsp;</strong>cells are formed as a result of acantholysis, which is the breakdown of <strong>intercellular connections</strong>, like <strong>desmosomes</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>This process leads to a reduction in cohesiveness among keratinocytes.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Acantholysis is classified as:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/25/screenshot-2023-11-25-114321.jpg\" alt=\"\" width=\"1000\" height=\"388\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Henderson Patterson bodies</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">These are <strong>intracytoplasmic</strong> inclusions seen in cells infected with <strong>molluscum contagiosum</strong>, a skin infection caused by the <strong>molluscum contagiosum virus</strong>.</span></li><li><span style=\"font-size:12pt;\">This is not consistent with the lesion shown in the image.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In <strong>Herpes simplex virus</strong> infections, scrapings from lesions may show both <strong>Acantholytic / Tzanck</strong> cells and <strong>Multinucleate giant cells (MNGCs).</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref -</strong>&nbsp;<strong>Ananthanarayan &amp; Paniker’s Textbook of Microbiology 10<sup>th</sup> edition Page no 474-476</strong></span></p>",
      "correct_choice_id": 40820,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10037,
      "choices": [
        {
          "id": 40114,
          "text": "<p><span style=\"font-size:12pt;\">Pox virus</span></p>"
        },
        {
          "id": 40115,
          "text": "<p><span style=\"font-size:12pt;\">Coxsackievirus</span></p>"
        },
        {
          "id": 40116,
          "text": "<p><span style=\"font-size:12pt;\">HHV-7</span></p>"
        },
        {
          "id": 40117,
          "text": "<p><span style=\"font-size:12pt;\">Parvovirus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which causative agent is responsible for the 4-year-old boy's condition, characterized by painful mouth sores, a rash on the hands, and fever as shown below? (</span>AIIMS Nov 2019)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-125720.png\" alt=\"\" width=\"400\" height=\"130\"></p><p>&nbsp;</p>",
      "unique_key": "Q2512334",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138910,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Coxsackievirus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The above scenario is suggestive of hand-foot-and-mouth disease. It is most commonly caused by <strong>coxsackievirus A16 (CV-A16).CV‐A6 and EV71</strong> are also other important causative organisms.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Age group commonly affected:&nbsp;</strong>Children.</span></li><li><span style=\"font-size:12pt;\"><strong>Spread:&nbsp;</strong>Droplets / fecal contamination.</span></li><li><span style=\"font-size:12pt;\"><strong>Incubation period:&nbsp;</strong>7 days.</span></li><li><span style=\"font-size:12pt;\"><strong>Clinical features:</strong> In children, the onset is with a <strong>low‐grade fever, sore throat and malaise</strong> but in adults, a painful stomatitis is an early feature.&nbsp;</span><ul><li><span style=\"font-size:12pt;\">Blisters in the mouth soon break down to superficial ulcers.</span></li><li><span style=\"font-size:12pt;\">Children are more likely than adults to develop <strong>flaccid greyish 2–5 mm oval vesicles</strong> on the palms and slightly less frequently on the soles.</span></li></ul></li><li><span style=\"font-size:12pt;\">They fade after 2–3 days. Infection can be subclinical.</span></li><li><span style=\"font-size:12pt;\">Only symptomatic treatment is given.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Pox virus:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Poxviruses cause diseases such as <strong>smallpox</strong> and <strong>molluscum contagiosum</strong>, which have very different clinical presentations from HFMD.</span></li><li><span style=\"font-size:12pt;\"><strong>Smallpox</strong>, which has been <strong>eradicated</strong>, presented with a characteristic <strong>vesicular and pustular</strong> rash and <strong>high mortality</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Molluscum contagiosum&nbsp;</strong>is characterized by firm, painless, <strong>umbilicated papules</strong>, not the presentation seen in the images provided.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. HHV-7 (Human Herpesvirus-7):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">HHV-7 is associated with <strong>roseola</strong>, a viral infection characterized by a <strong>high fever and a rash</strong>.</span></li><li><span style=\"font-size:12pt;\">HHV 7 is also associated with Pityriasis rosea.</span></li><li><span style=\"font-size:12pt;\">However, it does not typically cause painful mouth sores or a rash on the hands.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Parvovirus</strong>: Parvovirus <strong>B19</strong> can cause a condition called <strong>fifth disease</strong>, which may result in a <strong>rash on the face classically described as slapped cheek appearance as shown in the below image</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><i><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture7.jpg\" alt=\"\" width=\"600\" height=\"185\"></strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">but <strong>parvo virus</strong> not known for causing painful mouth sores or a rash on the hands. Additionally, fifth disease is more common in children between <strong>5 and 15 years old</strong>, so it is less likely in a 4-year-old.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The clinical presentation of <strong>fever, painful oral sores</strong>, and a <strong>vesicular rash</strong> on the <strong>hands and feet</strong> in a young <strong>child</strong> is characteristic of <strong>Hand, Foot, and Mouth Disease</strong>, which is <strong>most commonly</strong> caused by <strong>Coxsackievirus.</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-130109.png\" alt=\"\" width=\"1000\" height=\"709\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rook's Textbook of Dermatology -9th Edition, Chapter 25 Page no 25.81, chapter 117, Page no 117.6</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Fitzpatrick’s dermatology, 9<sup>th</sup> edition, Page no 1591</strong></span></p>",
      "correct_choice_id": 40115,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10088,
      "choices": [
        {
          "id": 40318,
          "text": "<p><span style=\"font-size:12.0pt;\">Epidermolysis bullosa</span></p>"
        },
        {
          "id": 40319,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic bullous disorder of childhood</span></p>"
        },
        {
          "id": 40320,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital syphilis</span></p>"
        },
        {
          "id": 40321,
          "text": "<p><span style=\"font-size:12.0pt;\">Neonatal pemphigus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A male baby, born to a non-consanguineous couple, presents with blisters on areas of friction. Their previous baby also experienced similar issues and unfortunately passed away at the age of 2 weeks. What is the probable diagnosis?(</span>INICET Nov 2020)</p>",
      "unique_key": "Q3215100",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138911,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Epidermolysis bullosa</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The male baby's current condition, characterized by <strong>blisters</strong> appearing in areas of <strong>friction</strong>, along with a <strong>similar history in a sibling</strong>, strongly suggests a diagnosis of a <strong>genetic </strong>condition called as <strong>epidermolysis bullosa congenita</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Epidermolysis bullosa is a <strong>mechano-bullous disease</strong> where blisters develop in response to <strong>mechanical trauma</strong>, often occurring in regions prone to friction such as the <strong>hands, feet, elbows, and knees</strong>.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13544.jpg\" alt=\"\" width=\"500\" height=\"424\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Various types of Epidermolysis bullosa (EB) &amp; Defects associated with them:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/screenshot-2023-11-27-092626.jpg\" alt=\"\" width=\"1000\" height=\"307\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-133525.png\" alt=\"\" width=\"1000\" height=\"661\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The likely diagnosis in a <strong>neonate</strong> presenting with <strong>blistering</strong> at areas of <strong>friction</strong>, especially with a similar <strong>family history</strong> and <strong>early demise in a sibling</strong>, is Epidermolysis bullosa, a genetic condition causing <strong>extremely fragile skin</strong> leading to blister formation with <strong>minimal trauma.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Rook's Textbook of Dermatology - 9th Edition - Volume I Chapter 71 Page no 71.4-71.16</strong></span></p>",
      "correct_choice_id": 40318,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59691,
      "choices": [
        {
          "id": 238077,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alopecia areata</span></span></span></p>"
        },
        {
          "id": 238078,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Androgenic alopecia</span></span></span></p>"
        },
        {
          "id": 238079,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Loose anagen hair</span></span></span></p>"
        },
        {
          "id": 238080,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trichotillomania</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 27-year-old married woman presents with patchy hair loss in the right temporal and occipital areas. Upon examination, she exhibits non-scarring alopecia with several short, broken hairs. Scalp scrapings reveal mild inflammation, peri-follicular hemorrhage, and a slight lymphocytic infiltration. What is the most probable diagnosis? (AIIMS NOV 2016)</span></span></span></p>",
      "unique_key": "Q1546298",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138912,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Correct Answer</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: <strong>D. TRICHOTILLOMANIA</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The clinical presentation of patchy hair loss with non-scarring alopecia and the presence of short, broken hairs in the temporal and occipital regions strongly suggests trichotillomania. This condition involves compulsive hair-pulling behavior, leading to the distinct findings of broken hairs and mild perifollicular inflammation, as observed on scalp examination. The peri-follicular hemorrhage and mild lymphocytic infiltration seen in the scrapings further support this diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option A. Alopecia areata:</strong> Typically presents with smooth, round patches of hair loss without broken hairs or significant inflammation.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option B. Androgenic alopecia:</strong> Characterized by diffuse hair thinning rather than patchy hair loss, and it generally does not involve broken hairs or inflammation.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option C. Loose anagen hair:</strong> This condition involves easily extractable hairs in the anagen phase but does not present with patchy hair loss and broken hairs like trichotillomania.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trichotillomania is identified by patchy hair loss with short, broken hairs, often due to compulsive hair-pulling behavior.</span></span></p>",
      "correct_choice_id": 238080,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7478,
      "choices": [
        {
          "id": 29880,
          "text": "<p><span style=\"font-size:12pt;\">Topical steroids therapy</span></p>"
        },
        {
          "id": 29881,
          "text": "<p><span style=\"font-size:12pt;\">Anti-leprosy treatment</span></p>"
        },
        {
          "id": 29882,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-fungal therapy</span></p>"
        },
        {
          "id": 29883,
          "text": "<p><span style=\"font-size:12pt;\">Anti-tubercular therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the drug used to treat the condition shown below: (NEET PG 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/449.jpg\" alt=\"\" width=\"300\" height=\"216\"></span></p>",
      "unique_key": "Q5092084",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138913,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;D. Anti-tubercular therapy</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The image showing a plaque with <strong>one margin extending &amp; other margin healing with scarring</strong> (Asymmetrical lesion), this favors to the diagnosis of <strong>lupus vulgaris</strong>, which is treated using anti-tubercular drugs.</span></li><li><span style=\"font-size:12pt;\">It is the <strong>most common cutaneous tuberculosis in adults in India</strong>.</span></li><li><span style=\"font-size:12pt;\">It occurs in previously sensitized hosts with good immunity.</span></li><li><span style=\"font-size:12pt;\"><strong>Granulomas with little to no caseation can be seen on histology.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Lupus Vulgaris</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Lupus vulgaris is a chronic form of skin TB seen in patients with <strong>moderate immunity</strong> to TB bacilli</span></li><li><span style=\"font-size:12pt;\">It is seen more common in females.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Pathogenesis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It occurs due to <strong>hematogenous</strong>, lymphatic, or <strong>contiguous</strong> spread from elsewhere in the body, or from <strong>exogenous</strong> inoculation. It occurs in <strong>previously sensitized</strong> hosts with <strong>good immunity, hence Paucibacillary.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Clinical features</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It presents as single or few lesions which are well demarcated, annular plaques which extend centrifugally. Periphery show erythematous deep-seated nodules which on diascopy may stand out as <strong>apple jelly nodules as seen in the image below</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/28/screenshot-2023-09-27-194250.jpg\" alt=\"\" width=\"400\" height=\"300\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">&nbsp;They are most commonly seen in buttocks, upper extremities, and face. Center is depigmented with paper-thin scar with nodules.</span></li><li><span style=\"font-size:12pt;\">Papules may recur on the scarred areas, which enlarge and coalesce. This leads to the formation of large, firm, elevated plaques.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Diagnosis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Histologic examination &amp; a positive culture for <strong>M. tuberculosis/ bovis</strong> confirm the diagnosis</span></li><li><span style=\"font-size:12pt;\">Most prominent histopathologic feature: <strong>Typical granulomas</strong> with scanty or absent caseation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Complication</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Secondary <strong>scarring</strong> <strong>&amp; squamous cell carcinomas</strong> may develop rarely.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Treatment:</span></p><p><span style=\"font-size:12pt;\"><strong>Anti-tubercular drugs.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>CLASSIFICATION OF CUTANEOUS TUBERCULOSIS IS BASED ON THE MODE OF ACQUISITION:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/15/screenshot-2024-06-15-101358.png\" alt=\"\" width=\"800\" height=\"529\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Topical steroids therapy</strong>:</span></p><ul><li><span style=\"font-size:12pt;\">This is not the appropriate treatment for lupus vulgaris.</span></li><li><span style=\"font-size:12pt;\">Topical steroids are used for inflammatory conditions, and while they may reduce inflammation and symptoms temporarily, they do <strong>not address</strong> the underlying <strong>mycobacterial infection</strong> that causes lupus vulgaris.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Anti-leprosy treatment</strong>:</span></p><ul><li><span style=\"font-size:12pt;\">Although leprosy is also caused by a <strong>mycobacterium (Mycobacterium leprae)</strong> and anti-leprosy drugs are used to treat it, the clinical features described do not match leprosy.</span></li><li><span style=\"font-size:12pt;\">Moreover, the treatment regimens for leprosy and tuberculosis are different.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Anti-fungal therapy</strong>:</span></p><ul><li><span style=\"font-size:12pt;\">Fungal infections can present with skin lesions, but the description of the lesion as characteristic of lupus vulgaris does not fit a fungal infection.</span></li><li><span style=\"font-size:12pt;\">Anti-fungal therapy would not be effective against mycobacterial infections.</span></li></ul><p>&nbsp;</p><p><span style=\"color:#0f0f0f;font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:#0f0f0f;font-size:12pt;\"><strong>Lupus vulgaris</strong> is a form of <strong>cutaneous tuberculosis</strong> characterized by <strong>irregular plaques</strong> that show <strong>progression at one margin</strong> and <strong>healing with scarring</strong> at another, and to understand that the appropriate treatment is a multi-drug <strong>anti-tubercular therapy regimen.</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>References:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Rooks textbook of dermatology- 9<sup>th</sup> Edition page no 27.21-27.23, 32.35-32.36, 33.44-33.45</strong></span></p>",
      "correct_choice_id": 29883,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44006,
      "choices": [
        {
          "id": 175683,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acanthosis nigricans &ndash; Insulin resistance</span></span></span></p>"
        },
        {
          "id": 175684,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stria albicans &ndash; Cushing syndrome</span></span></span></p>"
        },
        {
          "id": 175685,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Xeroderma pigmentosum &ndash; Freckles</span></span></span></p>"
        },
        {
          "id": 175686,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Caf&eacute; au lait spots &ndash; McCune Albright syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An overweight 13-year-old girl has the following blackish discoloration on her neck, as shown in the image below. What is this condition and its association?&nbsp;</span></span>(INICET NOVEMBER 2023)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/14/screenshot-2024-05-13-181820.png\" style=\"height:261px; width:400px\" /></span></span></p>",
      "unique_key": "Q5927948",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138914,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A)&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acanthosis nigricans &ndash; Insulin resistance</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Acanthosis Nigricans</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This condition is characterized by <strong><em>velvety, hyperpigmented plaques</em></strong> typically found in the <strong><em>intertriginous a</em></strong>reas such as <strong><em>the neck, axilla, and groin</em></strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The lesion&rsquo;s appearance in the image is consistent with Acanthosis Nigricans. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is commonly associated with <strong><em>insulin resistance</em></strong> and can be a marker for <strong><em>type 2 diabetes mellitus</em></strong>, especially in the context of <strong><em>overweight or obesity</em></strong>, as seen in the patient.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Striae Albicans</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul style=\"list-style-type:square\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This refers to the <strong><em>white or silver stretch marks</em></strong> that occur when the skin has been stretched rapidly as in the case of <strong><em>rapid weight gain</em></strong> or with conditions like <strong><em>Cushing syndrome.</em></strong> </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong><em><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/14/screenshot-2024-05-13-181828.png\" style=\"height:195px; width:300px\" /></em></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul style=\"list-style-type:square\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">However, the image does not show stretch marks but rather a hyperpigmented, thickened area of skin.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Xeroderma Pigmentosum</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This is a rare <strong><em>genetic disorder</em></strong> characterized by extreme <strong><em>sensitivity</em></strong> to ultraviolet (UV) rays from sunlight, leading to an increased risk of <strong><em>skin cancer.</em></strong> </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong><em><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/14/screenshot-2024-05-13-181838.png\" style=\"height:424px; width:400px\" /></em></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The lesions associated with this condition are more <strong><em>freckle-like</em></strong> and do not resemble the thick, velvety texture seen in the image.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Caf&eacute; au lait spots</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">These are <strong><em>light brown to dark brown spots </em></strong>commonly associated with <strong><em>neurofibromatosis or McCune-Albright syndrome</em></strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/14/screenshot-2024-05-13-181849.png\" style=\"height:226px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Unlike Acanthosis Nigricans, caf&eacute; au lait spots are smooth in texture and uniform in pigmentation, not velvety or thickened.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><em><span style=\"font-size:12.0pt\">Recognize <strong>Acanthosis Nigricans </strong>by its <strong>velvety, hyperpigmented plaques </strong>on the <strong>neck </strong>and its association with <strong>insulin resistance</strong> in the context of obesity.</span></em></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Rooks textbook of dermatology 9<sup>th</sup> edition Page no 87.2</span></strong></span></span></p>",
      "correct_choice_id": 175683,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13935,
      "choices": [
        {
          "id": 55701,
          "text": "<p><span style=\"font-size:12.0pt;\">Maddox wing</span></p>"
        },
        {
          "id": 55702,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Maddox glass</span></p>"
        },
        {
          "id": 55703,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Maddox rod</span></p>"
        },
        {
          "id": 55704,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Phoropter</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the instrument:&nbsp;</span>&nbsp;(NEET PG 2019)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/untitled-129.jpg\" alt=\"\" width=\"300\" height=\"280\"></span></p>",
      "unique_key": "Q6545551",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138915,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Maddox rod</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The above instrument is a Maddox rod.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A Maddox rod is a specially constructed device, consisting of a series of parallel cylinders, that converts a point source of light into a line image. It can be used to test for horizontal and vertical deviations, and when used in conjunction with another Maddox rod, for cyclo deviations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Maddox Rod Test</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patient is asked to fix on a point light in the centre of Maddox tangent scale at a distance of 6 metres. A Maddox rod (which consists of many glass rods of red colour set together in a metallic disc) is placed in front of one eye with axis of the rod parallel to the axis of deviation.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/untitled-134_k6VeiAz.jpg\" alt=\"\" width=\"500\" height=\"324\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/untitled-135_4VSQBFs.jpg\" alt=\"\" width=\"500\" height=\"414\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Due to dissimilar images of the two eyes, fusion is broken and heterophoria becomes manifest. The number on the Maddox tangent scale where the red line falls will be the amount of heterophoria in degrees.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Maddox wing:</strong> An instrument used to measure the horizontal and vertical deviations at near using a different mechanism involving a scale and moving wings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Maddox glass:</strong> This term is not commonly used; it might refer to the Maddox rod or Maddox wing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Phoropter:</strong> An instrument used in refraction testing to determine eyeglass prescriptions, consisting of multiple lenses that can be rotated into place to assess visual acuity and lens power.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Maddox rod is an instrument consisting of parallel cylindrical lenses used to convert a point light source into a line image, aiding in the diagnosis of horizontal, vertical, and cyclo deviations in ocular alignment.</span></p>",
      "correct_choice_id": 55703,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "InstrumentsBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10230,
      "choices": [
        {
          "id": 40886,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 1 for 12 months</span></p>"
        },
        {
          "id": 40887,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 2 for 12 months</span></p>"
        },
        {
          "id": 40888,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 1 for 6 months</span></p>"
        },
        {
          "id": 40889,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 2 for 6 months</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">A 35-year-old patient presents to the outpatient department with a satellite skin lesion. On examination, the patient has one hypopigmented lesion and one thickened nerve. The images of two blister packs are provided. Based on the WHO / NLEP Guidelines, which treatment is most appropriate for this patient?</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/picture2_e7rPz6c.jpg\" alt=\"\" width=\"300\" height=\"216\"></span></p>",
      "unique_key": "Q8554025",
      "question_audio": null,
      "question_video": null,
      "map_id": 13138916,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<h3><span style=\"color:#1F3763;font-size:10.5pt;\">Answer:</span></h3><p><span style=\"font-size:10.5pt;\">The correct answer is <strong>B. Packet 2 for 12 months</strong>.</span></p><p><span style=\"font-size:13.5pt;\"><strong>Latest Guidelines for Leprosy: NLEP = WHO (from April 1, 2025)</strong></span></p><p>As of <strong>April 1, 2025</strong>, <strong>India's NLEP has aligned completely with WHO guidelines</strong> for the <strong>diagnosis and treatment of leprosy</strong>. This means that the <strong>same criteria and drug regimens</strong> are now followed globally and in India.</p><p>&nbsp;</p><figure class=\"table\"><table><tbody><tr><td style=\"background-color:#4472C4;border:1.0pt solid #4472C4;height:21.0pt;padding:.75pt;width:494.25pt;\" colspan=\"3\"><span style=\"color:white;font-size:9.0pt;\"><strong>World health organization (WHO)&nbsp;</strong></span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:28.5pt;padding:.75pt;width:288.75pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Cardinal features</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:105.0pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Paucibacillary&nbsp;</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:100.5pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Multibacillary&nbsp;</strong></span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:35.25pt;padding:.75pt;width:288.75pt;\"><span style=\"font-size:9.0pt;\"><strong>Skin: Hypopigmented/ Hypoanesthetic patches</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:105.0pt;\"><span style=\"font-size:9.0pt;\">1-5&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:100.5pt;\"><span style=\"font-size:9.0pt;\">≥6</span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:34.5pt;padding:.75pt;width:288.75pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Nerves thickened +/- tenderness</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:105.0pt;\"><span style=\"color:black;font-size:9.0pt;\">No&nbsp;</span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:100.5pt;\"><span style=\"color:black;font-size:9.0pt;\">≥1&nbsp;</span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:20.25pt;padding:.75pt;width:288.75pt;\"><span style=\"font-size:9.0pt;\"><strong>SSS AFB</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:105.0pt;\"><span style=\"font-size:9.0pt;\">Absent&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:100.5pt;\"><span style=\"font-size:9.0pt;\">Present&nbsp;</span></td></tr></tbody></table></figure><p><span style=\"font-size:10.5pt;\"><i>*If a case has any one of the three features suggestive of MB, he/she is classified as MB.</i></span></p><p>&nbsp;</p><p><span style=\"font-size:13.5pt;\"><strong>Treatment Regimen: WHO &amp; NLEP (Post April 1st 2025)</strong></span></p><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_TAhJtvE.png\" alt=\"A chart of medication\r\n\r\n\r\n\r\n\r\n\r\nDescription automatically generated with medium confidence\" width=\"337\" height=\"172\"></span></p><figure class=\"image\"><img style=\"aspect-ratio:184/239;\" src=\"https://tnhealth.tn.gov.in/tngovin/dph/images/mbadultdose.png\" alt=\"Health &amp; Family Welfare Department, Government of Tamil Nadu\" width=\"184\" height=\"239\"></figure><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_QuOAkXI.png\" width=\"463\" height=\"250\"></span></p><p>&nbsp;</p><h3><span style=\"color:#1F3763;font-size:10.5pt;\">Other Options:</span></h3><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\"><strong>Option A: Packet 1 for 12 months:</strong>&nbsp;</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\">This packet was used for the treatment of paucibacillary leprosy according to old guidelines of NLEP, which is not suitable for a patient with multibacillary leprosy.</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\"><strong>Option C: Packet 1 for 6 months:&nbsp;</strong></span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\">This packet was used for the treatment of paucibacillary leprosy according to old guidelines of NLEP, which is not suitable for a patient with multibacillary leprosy.</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\"><strong>Option D Packet 2 for 6 months:</strong>&nbsp;</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\">Although Packet 2 contains the correct medications, the treatment duration of 6 months is insufficient for multibacillary leprosy according to WHO guidelines, which recommends 12 months.</span></p><p>&nbsp;</p><p><strong>OLD NLEP GUIDELINES to diagnose Leprosy&nbsp;</strong></p><figure class=\"table\"><table><tbody><tr><td style=\"background-color:#4472C4;border:1.0pt solid #4472C4;height:21.0pt;padding:.75pt;width:469.5pt;\" colspan=\"3\"><span style=\"color:white;font-size:9.0pt;\"><strong>National Leprosy Eradication Programme (NLEP)&nbsp;</strong></span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:28.5pt;padding:.75pt;width:281.9pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Cardinal features</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:91.3pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Paucibacillary&nbsp;</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:96.3pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Multibacillary&nbsp;</strong></span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:35.25pt;padding:.75pt;width:281.9pt;\"><span style=\"font-size:9.0pt;\"><strong>Skin: Hypopigmented/ Hypoanesthetic patches</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:91.3pt;\"><span style=\"font-size:9.0pt;\">1-5&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:96.3pt;\"><span style=\"font-size:9.0pt;\">≥6</span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:34.5pt;padding:.75pt;width:281.9pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Nerves thickened +/- tenderness</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:91.3pt;\"><span style=\"color:black;font-size:9.0pt;\">No or 1 nerve</span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:96.3pt;\"><span style=\"color:black;font-size:9.0pt;\">&gt;1&nbsp;</span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:20.25pt;padding:.75pt;width:281.9pt;\"><span style=\"font-size:9.0pt;\"><strong>SSS AFB</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:91.3pt;\"><span style=\"font-size:9.0pt;\">Absent&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:96.3pt;\"><span style=\"font-size:9.0pt;\">Present&nbsp;</span></td></tr></tbody></table></figure><p><strong>OLD NLEP GUIDELINES to treat Leprosy&nbsp;</strong></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cv8eRBC.png\" alt=\"A chart of drugs and drugs\r\n\r\nAI-generated content may be incorrect.\" width=\"468\" height=\"243\"></p><p><strong>OLD PB MDT with 2 drugs followed by NLEP:</strong></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_F3OLXAd.png\" alt=\"A green label with black circles and white text\r\n\r\nAI-generated content may be incorrect.\" width=\"468\" height=\"257\"></p><p>&nbsp;</p><p><span style=\"font-size:10.5pt;\"><i><strong>Educational objective:</strong></i></span></p><ul><li>As of <strong>April 1, 2025</strong>, <strong>NLEP follows WHO guidelines</strong> for both <strong>diagnosis and treatment</strong>.</li><li>Classification is based on <strong>skin lesions</strong>, <strong>nerve involvement</strong>, and <strong>skin smear</strong>.</li><li><span style=\"font-size:10.5pt;\">For a patient with <i><strong>multibacillary leprosy</strong></i>, characterized by <i><strong>one or more thickened nerves</strong></i> and <i><strong>multiple skin lesions</strong></i>, the appropriate treatment is with a regimen containing <i><strong>rifampicin, clofazimine, and dapsone (Packet 2)</strong></i> for a duration of <i><strong>12 months.</strong></i></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:10.5pt;\"><strong>References:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>Jopling’s handbook of leprosy, 6<sup>th</sup> edition, page no 10</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>Andrew’s diseases of the skin: clinical dermatology 13<sup>th</sup> edition page no 338, 339, 345</strong></span></p>",
      "correct_choice_id": 40887,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20342,
      "choices": [
        {
          "id": 81329,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital rubella syndrome</span></p>"
        },
        {
          "id": 81330,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital herpes simplex virus infection</span></p>"
        },
        {
          "id": 81331,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital toxoplasmosis</span></p>"
        },
        {
          "id": 81332,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital cytomegalovirus infection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An infant is brought to OPD with hepatosplenomegaly and thrombocytopenia. Neuroimaging with CT reveals periventricular calcifications. What is the most likely diagnosis? (NEET PG 2023)</span></p>",
      "unique_key": "Q2188716",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139198,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Congenital cytomegalovirus infection</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Congenital CMV is reported to be the commonest congenital infection. The overall transmission rate with primary infection is 30% and 10% of all babies infected are symptomatic. Congenital infection can affect all organ systems. Periventricular calcification is characteristic. The diagnosis of congenital CMV is confirmed by a positive IgM in the first two weeks of life.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/01/whatsapp-image-2023-06-12-at-190121015.jpg\" alt=\"\" width=\"200\" height=\"276\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Congenital rubella syndrome</strong>: Rubella causes most severe form of intra uterine infection. If infection sets within 11 weeks POG – 90% defects, if 11-12 weeks – 33% defects chances. More the weeks pass, less is the frequency of having CRS infections. Presentation is similar like measles rash but rash appears on day 1 &amp; lasts for 3 days (3 days measles). Triad – congenital heart disease (MC – PDA; Least Common – ASD), Cataract and Sensorineural Hearing loss (SNHL).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Congenital herpes simplex virus infection</strong>: The transmission of HSV to babies usually occurs during delivery in mothers who develop primary genital herpes at that time. Infected babies may be asymptomatic or have fulminant disease. Presents with vesicular eruption on to skin, eyes and mouth. CNS disease that presents as meningitis with seizures and altered sensorium. Diagnosis is by Tzanck smear of the skin lesions, culture or PCR of lesions or cerebrospinal fluid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Congenital toxoplasmosis</strong>: Congenital toxoplasmosis occurs due to maternal primary infection, which is generally subclinical may lead to fetal infection and disease. The transmissibility increases but the risk of fetal disease decreases with advancing pregnancy. It presents with a triad of chorioretinitis, hydrocephalus, and intracerebral calcifications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/01/whatsapp-image-2023-06-12-at-190121016.jpg\" alt=\"\" width=\"597\" height=\"162\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Periventricular calcifications on neuroimaging, along with hepatosplenomegaly and thrombocytopenia, are characteristic of congenital cytomegalovirus infection.</span></p>",
      "correct_choice_id": 81332,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44831,
      "choices": [
        {
          "id": 178971,
          "text": "<p><span style=\"font-size:12pt;\">Dravet Syndrome</span></p>"
        },
        {
          "id": 178972,
          "text": "<p><span style=\"font-size:12pt;\">Tuberous sclerosis</span></p>"
        },
        {
          "id": 178973,
          "text": "<p><span style=\"font-size:12pt;\">Rett syndrome</span></p>"
        },
        {
          "id": 178974,
          "text": "<p><span style=\"font-size:12pt;\">Lennox Gastaut syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Cannabinoids are not approved for treatment of (</span>INICET May 2024)</p>",
      "unique_key": "Q3673868",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139199,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Rett syndrome</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Cannabinoids, including cannabidiol (CBD), are not currently approved for the treatment of Rett syndrome.&nbsp;</span></li><li><span style=\"font-size:12pt;\">Rett syndrome is a rare genetic neurological disorder, and while there is ongoing research into potential treatments, cannabinoids are not among the approved therapies for this condition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>Dravet Syndrome</strong>: Cannabidiol (CBD) is approved for the treatment of Dravet Syndrome, a severe form of epilepsy. It is used to reduce the frequency of seizures in patients with this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Tuberous sclerosis</strong>: Cannabidiol (CBD) is also approved for the treatment of seizures associated with Tuberous Sclerosis Complex (TSC). It has been shown to reduce seizure frequency in patients with TSC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Lennox Gastaut syndrome</strong>: Cannabidiol (CBD) is approved for the treatment of Lennox-Gastaut Syndrome, another severe form of epilepsy. It is used to help reduce the frequency of seizures in patients with this syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, cannabinoids, specifically cannabidiol (CBD), are not approved for the treatment of Rett syndrome, whereas they are approved for use in Dravet Syndrome, Tuberous Sclerosis, and Lennox-Gastaut Syndrome.</span></p>",
      "correct_choice_id": 178973,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6531,
      "choices": [
        {
          "id": 26093,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B6</span></p>"
        },
        {
          "id": 26094,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B12</span></p>"
        },
        {
          "id": 26095,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B2</span></p>"
        },
        {
          "id": 26096,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A tuberculosis patient receiving anti-tubercular treatment complains of tingling and paresthesia in the lower limbs. He is not diabetic and drinks alcohol on occasion. Which of the following vitamins should be given to this patient?</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2022)</span></p>",
      "unique_key": "Q8969848",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139200,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Vitamin B6</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms of tingling and paresthesia in the lower limbs, in the context of receiving anti-tubercular treatment, are suggestive of peripheral neuropathy. One of the mainstays of tuberculosis (TB) treatment includes the drug isoniazid, which is known to cause vitamin B6 (pyridoxine) deficiency. Supplementing with vitamin B6 can prevent or alleviate these symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Vitamin B12</strong>: While vitamin B12 deficiency can cause peripheral neuropathy, it is not typically associated with anti-tubercular therapy. Vitamin B12 deficiency is more commonly linked to conditions like pernicious anemia or dietary deficiencies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vitamin B2 (Riboflavin):</strong> Deficiency of vitamin B2 can lead to various symptoms, including skin disorders and anemia, but it is not specifically linked to the type of neuropathy seen in patients taking isoniazid for TB.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vitamin B3 (Niacin):</strong> Deficiency of vitamin B3 leads to pellagra, characterized by dermatitis, diarrhea, and dementia, and is not associated with the peripheral neuropathy observed in patients on isoniazid therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patients receiving isoniazid as part of anti-tubercular therapy should be supplemented with vitamin B6 (pyridoxine) to prevent or treat peripheral neuropathy, a common side effect of this medication.</span></p>",
      "correct_choice_id": 26093,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49032,
      "choices": [
        {
          "id": 195703,
          "text": "<p><span style=\"font-size:18px;\">Patients requiring cataract surgeries are selected and asked to report to base hospital</span></p>"
        },
        {
          "id": 195704,
          "text": "<p><span style=\"font-size:18px;\">Perform more small incision cataract surgery</span></p>"
        },
        {
          "id": 195705,
          "text": "<p><span style=\"font-size:18px;\">To do surgery in rural area with make shift hospital/Ots</span></p>"
        },
        {
          "id": 195706,
          "text": "<p><span style=\"font-size:18px;\">To perform surgeries in fixed facility surgery by shifting patients from rural area.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A 70-year-old patient with a history of progressive vision loss is scheduled for cataract surgery under the National Program for Control of Blindness and Visual Impairment. Which of the following is NOT an accurate guideline or inclusion criterion for cataract surgery within this national program?</strong><i><strong> [INICET NOV 2023]</strong></i></span></p>",
      "unique_key": "Q8881162",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139201,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) To do surgery in rural area with make shift hospital/Ots</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>To do surgery in rural area with makeshift hospital/Ots i</strong>s not advisable, suggests conducting surgeries in temporary setups or less equipped facilities, typically in rural areas. This is considered unsafe and against the guidelines because such environments cannot guarantee the sterility and safety standards required for surgical procedures.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Patients requiring cataract surgeries are selected and asked to report to base hospital</strong>: This refers to the standard protocol where patients identified as needing cataract surgery are instructed to come to a base or main hospital that is equipped for such procedures. This ensures that surgeries are performed in a controlled, sterile environment with appropriate medical facilities and staff.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Perform more small incision cataract surgery (SICS)</strong>: This statement encourages the adoption of small incision cataract surgery, which is a modern technique that allows for quicker recovery times and potentially fewer complications than traditional methods. It is particularly advantageous in resource-limited settings because it does not require expensive machinery like phacoemulsification units.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. To perform surgeries in fixed facility surgery by shifting patients from rural area</strong>: This approach involves transporting patients from rural and remote areas to fixed, well-equipped surgical facilities, typically located in urban or suburban centers. This ensures all patients receive high-quality care in facilities that meet national and international health and safety standards.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective </strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The primary aim of these guidelines is to ensure that all surgeries, particularly sensitive ones like cataract surgery, are performed in environments that uphold the highest standards of medical care and patient safety. The emphasis is on using modern surgical techniques and ensuring that all procedures are carried out in well-equipped, permanent medical facilities to minimize risks and enhance recovery outcomes. The standard guideline includes:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:18px;\">Village Register (Linelisting of cases)</span></li><li><span style=\"font-size:18px;\">Screening camps</span></li><li><span style=\"font-size:18px;\">Transport of cases to Base hospital</span></li><li><span style=\"font-size:18px;\">Free surgery – fixed facility surgery approach (Reach in approach at base Hospitals preferred over Reach out approach as camp mode)</span></li><li><span style=\"font-size:18px;\">Follow up of cases (for this camp mode is preferred)</span></li></ol>",
      "correct_choice_id": 195705,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14014,
      "choices": [
        {
          "id": 56017,
          "text": "<p><span style=\"font-size:12.0pt;\">Wide bore needle insertion in the 5th intercostal space (ICS)</span></p>"
        },
        {
          "id": 56018,
          "text": "<p><span style=\"font-size:12.0pt;\">Wide bore needle insertion in the 5th ICS followed by an intercostal drain in the 5th ICS</span></p>"
        },
        {
          "id": 56019,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspiration of the pleural fluid</span></p>"
        },
        {
          "id": 56020,
          "text": "<p><span style=\"font-size:12.0pt;\">No intervention needed</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old female patient was brought to the ER after RTA, her RR is 22/min, BP is 90/60mmHg. On examination, hyper-resonance is heard over the right side of the chest. The chest X-ray performed is given below. What would be the appropriate management in this case? (AIIMS MAY 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-95_9PDkssD.jpg\" alt=\"\" width=\"208\" height=\"239\"></span></p>",
      "unique_key": "Q6977703",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139202,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Wide bore needle insertion in the 5th ICS followed by an intercostal drain in the 5th ICS</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given scenario of tachypnea, hypotension, hyper-resonance and x ray showing absent right broncho-vascular markings is suggestive of tension pneumothorax.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This option correctly addresses the likely diagnosis of a pneumothorax. The initial needle insertion can decompress the tension pneumothorax, and subsequent placement of an intercostal drain allows for continuous drainage of pleural air or fluid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A. Wide bore needle insertion in the 5th ICS</strong>: This option suggests inserting a needle into the 5th ICS to relieve tension pneumothorax, which can occur due to trauma. While this can be a life-saving procedure, the presence of hyper-resonance on examination suggests a pneumothorax, but it does not address the drainage of pleural fluid, which is the primary concern in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Aspiration of the pleural fluid</strong>: Aspiration of pleural fluid may be indicated in cases of pleural effusion, but it does not address the likely pneumothorax seen in this patient's presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D.</strong> <strong>No intervention needed</strong>: With the patient's clinical presentation, including respiratory distress, low blood pressure, and hyper-resonance, intervention is indeed needed. Failure to intervene could lead to worsening respiratory compromise and potentially life-threatening consequences.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Tension pneumothorax usually occurs due to trauma, such as a rib fracture, a puncture wound, or chest surgery, but it can also develop spontaneously in patients with underlying lung diseases, such as emphysema or cystic fibrosis.</span></li><li><span style=\"font-size:12.0pt;\">Immediate treatment of tension pneumothorax is essential to prevent respiratory and cardiac arrest. The first step is to perform needle decompression, which involves inserting a large-bore needle into the affected side of the chest to release the trapped air in the triangle of safety. After that, a chest tube is inserted to further drain the air and prevent the reoccurrence of a pneumothorax.</span></li></ul>",
      "correct_choice_id": 56018,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5940,
      "choices": [
        {
          "id": 23730,
          "text": "<p><span style=\"font-size:12pt;\">6-8 weeks</span></p>"
        },
        {
          "id": 23731,
          "text": "<p><span style=\"font-size:12pt;\">11-14 weeks</span></p>"
        },
        {
          "id": 23732,
          "text": "<p><span style=\"font-size:12pt;\">14-16 weeks</span></p>"
        },
        {
          "id": 23733,
          "text": "<p><span style=\"font-size:12pt;\">16-20 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the ideal time for nuchal translucency evaluation? (NEET PG 2019)</span></p>",
      "unique_key": "Q1069719",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139203,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 11-14 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Nuchal Translucency (NT):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Definition:</strong> Nuchal translucency refers to the maximum thickness of the subcutaneous translucent area between the skin and soft tissue overlying the fetal spine at the back of the neck.</span></li><li><span style=\"font-size:12pt;\"><strong>Significance:</strong> An increased NT measurement is associated with an increased risk for fetal aneuploidy (such as Down syndrome) and various structural anomalies including cardiovascular defects, hydrops fetalis, and cystic hygroma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Timing:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">NT is measured between <strong>11 weeks</strong> and <strong>13 weeks 6 days</strong> (or <strong>11-14 weeks</strong>) of gestation. This time frame is critical as it ensures the accuracy of the measurement and its correlation with potential anomalies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Measurement Criteria:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Crown-Rump Length (CRL):</strong> Should be between 45-84 mm.</span></li><li><span style=\"font-size:12pt;\"><strong>Fetal Position:</strong> Fetus should be in the mid-sagittal plane and in a neutral position.</span></li><li><span style=\"font-size:12pt;\"><strong>Image Quality:</strong> The image must be magnified, and the widest space should be measured.</span></li><li><span style=\"font-size:12pt;\"><strong>Caliper Placement:</strong> The ‘+’ calipers must be placed on the inner borders of the nuchal space, ensuring the amnion is seen separately.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Screening Efficiency:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>NT Alone:</strong> Provides a 65% detection rate for Down syndrome.</span></li><li><span style=\"font-size:12pt;\"><strong>Combined Test:</strong> When combined with the Dual Marker test (beta hCG and PAPP-A), the detection rate for Down syndrome improves to 80%.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. 6-8 weeks:</strong> This is too early for accurate NT measurement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. 14-16 weeks:</strong> This is beyond the optimal time frame for NT evaluation, reducing the effectiveness of the screening.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. 16-20 weeks:</strong> This period is too late for NT measurement, which should be performed in the first trimester.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The ideal time for nuchal translucency evaluation is between 11-14 weeks of gestation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/14/untitled-77.jpg\" alt=\"\" width=\"300\" height=\"241\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 860, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23731,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30512,
      "choices": [
        {
          "id": 121926,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To allay anxiety</span></span></span></p>"
        },
        {
          "id": 121927,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To decrease secretions</span></span></span></p>"
        },
        {
          "id": 121928,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">As inducing agent</span></span></span></p>"
        },
        {
          "id": 121929,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For muscle relaxation</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">A patient was schedule for surgery. Before giving anaesthesia, he was administered glycopyrrolate. What is rationale of giving glycopyrrolate before anaesthesia?</span></span></span></span>(AIIMS NOV 2019)</p>",
      "unique_key": "Q6676221",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139205,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans. B. To decrease secretions</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Preanesthetic medication refers to the use of drugs before anaesthesia to make it safe and less unpleasant.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">When inhalation anaesthetic agents are given, they inhibit the ciliary function resulting in accumulation of secretions in the respiratory pathway. Therefore anti-cholinergic drugs like atropine or glycopyrrolate are used as pre-anaesthetic medication for their anti-secretory action.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Glycopyrrolate is twice as potent and longer acting quaternary anti-muscarinic which does not produce central effects. Anti-secretory action is more marked than atropine and tachycardia is less marked. It acts rapidly when given i.v. and is the preferred anti-muscarinic in anaesthetic practice.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. To allay anxiety:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Glycopyrrolate is not used to allay anxiety. Anxiolytics such as benzodiazepines are typically used for this purpose.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. As inducing agent:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Glycopyrrolate is not an inducing agent. Inducing agents are drugs like propofol or thiopental used to induce anaesthesia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. For muscle relaxation:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Glycopyrrolate is not used for muscle relaxation. Muscle relaxants like vecuronium or succinylcholine are used for this purpose during surgical procedures.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glycopyrrolate is administered before anaesthesia to decrease respiratory secretions, making the anaesthetic procedure safer and more efficient by preventing the accumulation of secretions that can interfere with the airway during surgery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: KDT 8th/. 413,414</span></span></strong></span></span></p>",
      "correct_choice_id": 121927,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4091,
      "choices": [
        {
          "id": 16343,
          "text": "<p><span style=\"font-size:12.0pt;\">A, B &amp; C only</span></p>"
        },
        {
          "id": 16344,
          "text": "<p><span style=\"font-size:12.0pt;\">A &amp; B only</span></p>"
        },
        {
          "id": 16345,
          "text": "<p><span style=\"font-size:12.0pt;\">A, B, C &amp; D</span></p>"
        },
        {
          "id": 16346,
          "text": "<p><span style=\"font-size:12.0pt;\">C &amp; D only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In which of the following situations will you use a sanitizer? (INICET NOV 2020)</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\">Before examining the patient</span></li><li><span style=\"font-size:12.0pt;\">After examining the patient</span></li><li><span style=\"font-size:12.0pt;\">After touching the patient's surroundings</span></li><li><span style=\"font-size:12.0pt;\">Hands are visibly soiled</span></li></ol>",
      "unique_key": "Q6783360",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139206,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) A, B and C only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Healthcare personnel should perform hand hygiene with soap and water when hands are visibly soiled.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Healthcare personnel should use an alcohol-based hand rub for the following clinical indications:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Immediately before touching a patient</span></li><li><span style=\"font-size:12.0pt;\">Before performing an aseptic task (e.g., placing an indwelling device) or handling invasive medical devices</span></li><li><span style=\"font-size:12.0pt;\">Before moving from work on a soiled body site to a clean body site on the same patient</span></li><li><span style=\"font-size:12.0pt;\">After touching a patient or the patient’s immediate environment</span></li><li><span style=\"font-size:12.0pt;\">After contact with blood, body fluids, or contaminated surfaces</span></li><li><span style=\"font-size:12.0pt;\">Immediately after glove removal</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>D. Hands are visibly soiled:</strong> In this case, hand washing with soap and water is recommended rather than using a sanitizer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Healthcare personnel should use hand sanitizer before and after examining a patient and after touching the patient's surroundings. However, when hands are visibly soiled, hand hygiene should be performed using soap and water instead of a sanitizer.</span></p>",
      "correct_choice_id": 16343,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5869,
      "choices": [
        {
          "id": 23446,
          "text": "<p><span style=\"font-size:12pt;\">Intensity is inversely proportional to squared distance</span></p>"
        },
        {
          "id": 23447,
          "text": "<p><span style=\"font-size:12pt;\">Small blood vessels are most radioresistant</span></p>"
        },
        {
          "id": 23448,
          "text": "<p><span style=\"font-size:12pt;\">Rapidly proliferating cells are most radioresistant</span></p>"
        },
        {
          "id": 23449,
          "text": "<p><span style=\"font-size:12pt;\">Small bowel is most radioresistant</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman with endometrial carcinoma is undergoing radiotherapy. Which of the following is true?&nbsp;</span>(NEET PF 2020)</p>",
      "unique_key": "Q9964437",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139207,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Intensity is inversely proportional to squared distance</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">This statement refers to the Inverse Square Law, which states that the intensity of radiation is inversely proportional to the square of the distance from the source. This means that as the distance from the radiation source increases, the intensity of the radiation decreases exponentially. This law is fundamental in radiation physics and is crucial for understanding radiation exposure and protection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Small blood vessels are most radioresistant:</strong> This is incorrect. Larger vessels are more radioresistant compared to smaller ones. The endothelial cells lining small vessels are more susceptible to radiation damage due to their relatively higher rate of proliferation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Rapidly proliferating cells are most radioresistant:</strong> This is incorrect. Rapidly proliferating cells are the most radiosensitive. Cells that are dividing quickly, such as those in the gastrointestinal tract, bone marrow, and reproductive tissues, are more susceptible to radiation damage because radiation primarily affects DNA during cell division.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Small bowel is most radioresistant:</strong> This is incorrect. The gastrointestinal (GI) tract, including the small bowel, is among the most radiosensitive organ systems in the body. This high radiosensitivity is due to the rapid turnover of the epithelial cells lining the GI tract.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The intensity of radiation is inversely proportional to the square of the distance from the source, as described by the Inverse Square Law.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 610, Williams Gynecology 3<sup>rd</sup> edition</strong></span></p>",
      "correct_choice_id": 23446,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9994,
      "choices": [
        {
          "id": 39942,
          "text": "<p><span style=\"font-size:12.0pt;\">NOTCH1</span></p>"
        },
        {
          "id": 39943,
          "text": "<p><span style=\"font-size:12.0pt;\">RB gene</span></p>"
        },
        {
          "id": 39944,
          "text": "<p><span style=\"font-size:12.0pt;\">CPK gene</span></p>"
        },
        {
          "id": 39945,
          "text": "<p><span style=\"font-size:12.0pt;\">AIRE</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During development, thymic cells recognizing self-antigens are removed to prevent autoimmunity. Which gene among the following is involved in the process? (AIIMS NOV 2017)</span></p>",
      "unique_key": "Q4807489",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139209,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) AIRE</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The above process is called central tolerance and the AIRE (Autoimmune Regulator) protein is necessary for this process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Immature self-reactive T and B lymphocyte clones recognize self-antigens during their maturation in the central lymphoid organs (thymus for T cells, bone marrow for B cells). They are killed or rendered harmless.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The removal of self-reacting T lymphocytes in the thymus is called <strong>negative selection/ deletion</strong>. A protein called AIRE (autoimmune regulator) stimulates expression of some “peripheral tissue-restricted” self-antigens in the thymus and is thus critical for deletion of immature T cells specific for these antigens. <strong>Mutations in the AIRE gene are the cause of an autoimmune polyendocrinopathy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">B cells undergo a process called receptor editing. When developing B cells encounter an antigen, it formulates a change in the receptor that makes the antigen unrecognizable. Self-reacting B cells can also undergo apoptosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. NOTCH1:</strong> Involved in T cell development but not specifically in the central tolerance process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. RB gene:</strong> A tumor suppressor gene involved in regulating the cell cycle, not in immune tolerance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. CPK gene:</strong> Not relevant to the process of central tolerance or immune regulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>AIRE gene</strong> is crucial for central tolerance in the thymus, preventing autoimmunity by ensuring the deletion of self-reactive T cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotran pathologic basis of disease, 8<sup>th</sup> edition, Page No. 397-398</strong></span></p>",
      "correct_choice_id": 39945,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54664,
      "choices": [
        {
          "id": 218121,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Live vaccine</span></span></span></p>"
        },
        {
          "id": 218122,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Given orally</span></span></span></p>"
        },
        {
          "id": 218123,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Found in monovalent &amp; pentavalent variant</span></span></span></p>"
        },
        {
          "id": 218124,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rotavirus should not be given after 6 months</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is not true regarding rotavirus vaccine?&nbsp;</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q9959709",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139210,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>D) Rotavirus should not be given after 6 months</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rotavirus vaccines are live, attenuated vaccines administered orally to protect against rotavirus infections, which can cause severe diarrhea in infants and young children. The vaccine is available in both monovalent and pentavalent forms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The statement &quot;Rotavirus should not be given after 6 months&quot; is incorrect. The catch-up schedule for the rotavirus vaccine allows for administration up to one year of age. The vaccination schedule generally involves doses at 2 and 4 months of age, with a possible third dose at 6 months depending on the vaccine used. However, the vaccine series should ideally be completed by 8 months of age.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Live vaccine:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is true. The rotavirus vaccine is a live attenuated vaccine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Given orally:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is true. The rotavirus vaccine is administered orally, not by injection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Found in monovalent &amp; pentavalent variant:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is true. The vaccine is available in both monovalent and pentavalent forms, targeting different strains of the virus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The catch-up schedule for the rotavirus vaccine extends up to one year of age, contrary to the incorrect statement that it should not be given after 6 months.</span></span></span></p>",
      "correct_choice_id": 218124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24730,
      "choices": [
        {
          "id": 98881,
          "text": "<p><span style=\"font-size:12.0pt;\">Total lack of natural killer cells</span></p>"
        },
        {
          "id": 98882,
          "text": "<p><span style=\"font-size:12.0pt;\">Lack of CD8 mediated cytotoxicity</span></p>"
        },
        {
          "id": 98883,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease in lgG and increase in lgM</span></p>"
        },
        {
          "id": 98884,
          "text": "<p><span style=\"font-size:12.0pt;\">Inability of neutrophils to fight against infections</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the subsequent statements accurately describes the immunological anomaly associated with the absence of CD40 in B cells?</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2023)</span></p>",
      "unique_key": "Q3961648",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139211,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Decrease in lgG and increase in lgM</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The absence of CD40 and its deficiency in B cells results in Hyper IgM syndrome. This condition is characterized by a reduction in IgG levels and an elevation in IgM levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>HYPER IGM SYNDROME</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125683.jpg\" alt=\"\" width=\"1000\" height=\"525\"></u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Total lack of natural killer cells</strong>: This is not associated with CD40 deficiency but rather with other immune disorders like severe combined immunodeficiency (SCID).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Lack of CD8 mediated cytotoxicity</strong>: CD40/CD40L interactions do not directly affect CD8 T cells. CD8 mediated cytotoxicity is more related to T cell receptor function and MHC class I interactions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Inability of neutrophils to fight against infections</strong>: While CD40 deficiency can lead to an increased susceptibility to infections, neutrophil function is not directly impaired by the absence of CD40. This function is more related to chronic granulomatous disease or other neutrophil defects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hyper IgM syndrome is characterized by an increased level of IgM and decreased levels of other immunoglobulins like IgG, due to a defect in the CD40/CD40L interaction necessary for immunoglobulin class switching.</span></p>",
      "correct_choice_id": 98883,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5808,
      "choices": [
        {
          "id": 23202,
          "text": "<p><span style=\"font-size:12pt;\">Immediate termination</span></p>"
        },
        {
          "id": 23203,
          "text": "<p><span style=\"font-size:12pt;\">Give surfactant and wait till 36 weeks</span></p>"
        },
        {
          "id": 23204,
          "text": "<p><span style=\"font-size:12pt;\">Do Doppler everyday to check for reversion</span></p>"
        },
        {
          "id": 23205,
          "text": "<p><span style=\"font-size:12pt;\">Terminate after 37 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female presents with 35 weeks and 3 days of gestation, AFI = 5 and there is no end-diastolic blood flow. What is the management?&nbsp;</span>(INICET MAY 2018)</p>",
      "unique_key": "Q4566498",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139212,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Immediate termination</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The scenario described indicates fetal compromise, specifically with the findings of oligohydramnios (AFI = 5) and absent end-diastolic flow in the umbilical artery Doppler. These are signs of severe placental insufficiency and fetal distress.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Absent or Reversed End-Diastolic Flow:</strong> This is a critical finding on Doppler ultrasound indicating severe fetal compromise. The absence of end-diastolic flow in the umbilical artery suggests that the fetus is not receiving adequate blood flow, leading to an increased risk of hypoxia and stillbirth.</span></li><li><span style=\"font-size:12pt;\"><strong>Management:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Immediate Termination:</strong> For pregnancies beyond 34 weeks, immediate delivery is indicated to prevent further fetal compromise. This is because the risks of continuing the pregnancy outweigh the benefits, given the significant risk of fetal hypoxia and potential demise.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Give surfactant and wait till 36 weeks:</strong> This is not appropriate because the immediate risk to the fetus requires prompt delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Do Doppler everyday to check for reversion:</strong> Continuous monitoring is insufficient in this scenario as the condition indicates severe fetal distress requiring urgent intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Terminate after 37 weeks:</strong> Waiting until 37 weeks is not appropriate due to the immediate risk of fetal compromise.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In cases of severe fetal compromise indicated by absent or reversed end-diastolic flow in the umbilical artery Doppler, especially beyond 34 weeks of gestation, immediate termination of the pregnancy is warranted to prevent fetal hypoxia and potential stillbirth.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 2141, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3506,
      "choices": [
        {
          "id": 14003,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A</span></span></p>"
        },
        {
          "id": 14004,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C</span></span></p>"
        },
        {
          "id": 14005,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></span></p>"
        },
        {
          "id": 14006,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Identify the condenser? </span>(<span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">INICET MAY 2020)</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/1-micro-33.jpg\" style=\"height:333px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q3125672",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139213,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) B </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">B</span></strong><span style=\"font-size:12.0pt\">: The condenser is located beneath the microscope stage and is used to focus light onto the specimen. It typically contains lenses that gather and concentrate light from the illuminator and direct it through the specimen for optimal viewing.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A</strong>: This is the coarse focusing knob, which is used to bring the specimen into general focus by moving the stage up and down.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C</strong>: This represents the objective lenses, which are used to magnify the specimen.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D</strong>: This is the illuminator, which is the light source that provides illumination for viewing the specimen.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/05/screenshot-2024-07-05-171743.png\" style=\"height:482px; width:600px\" /></p>",
      "correct_choice_id": 14005,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6465,
      "choices": [
        {
          "id": 25829,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phase 1</span></span></span></p>"
        },
        {
          "id": 25830,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phase 2</span></span></span></p>"
        },
        {
          "id": 25831,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phase 3</span></span></span></p>"
        },
        {
          "id": 25832,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phase 4</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following phases of a clinical trial is also referred to as efficacy trial?</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (NEET PG 2019)</span></span></p>",
      "unique_key": "Q5811904",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139214,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Phase 3</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phase 3 of a clinical trial is often referred to as an efficacy trial. This is because phase 3 trials are designed to evaluate the efficacy and safety of the investigational drug or intervention in a larger and more diverse patient population. Phase 3 trials typically involve several hundred to several thousand participants and are usually randomized, controlled trials that compare the investigational drug or intervention to either a placebo or an active comparator.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Phase 1</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> trials are typically the first-in-human studies and are designed to evaluate the safety, tolerability, and pharmacokinetics of the investigational drug or intervention.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Phase 2</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> trials are designed to evaluate the safety and preliminary efficacy of the investigational drug or intervention in a larger patient population than in phase 1 trials.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Phase 4</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> trials, also known as post-marketing surveillance studies, are conducted after a drug or intervention has been approved by regulatory agencies and are designed to monitor the long-term safety and effectiveness of the drug or intervention in a larger patient population than in earlier phases of the trial.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/08/screenshot-2024-10-08-132716.jpg\" style=\"height:300px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 25831,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5823,
      "choices": [
        {
          "id": 23262,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Supine with wedge under right hip</span></span></span></p>"
        },
        {
          "id": 23263,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Semi fowlers</span></span></span></p>"
        },
        {
          "id": 23264,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trendelenburg with legs stirrup</span></span></span></p>"
        },
        {
          "id": 23265,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prone position</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman presents with prolonged labor in emergency. She is being taken for a Cesarean section. Which of the following is the correct position in which the nurse should keep the patient on the OT table?&nbsp;</span></span>(INICET NOV 2018)</p>",
      "unique_key": "Q6047962",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139215,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Supine with wedge under right hip</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The preferred position for a cesarean section is supine with a wedge under the right hip. This positioning is crucial to prevent supine hypotension syndrome, which is commonly seen in the third trimester of pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Supine hypotension syndrome:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Occurs due to the pressure of the gravid uterus on the inferior vena cava (IVC) when the patient is in the supine position.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This pressure can cause hypotension, tachycardia, and syncope.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is particularly dangerous during cesarean sections where spinal anesthesia can exacerbate hypotension.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A right tilt (placing a wedge under the right hip) helps to alleviate the pressure on the IVC, thereby preventing hypotension.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Semi fowlers:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The individual lies on the bed with the head elevated 30-45 degrees. This position is not suitable for a cesarean section.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Trendelenburg with legs stirrup:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This position involves having the head low and is not appropriate for a cesarean section. The reverse Trendelenburg position (head high) is also not suitable for this purpose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Prone position:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The prone position (lying face down) is inappropriate for cesarean sections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During a cesarean section, the patient should be positioned supine with a wedge under the right hip to prevent supine hypotension syndrome, which is caused by the pressure of the gravid uterus on the inferior vena cava.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 26<sup>th</sup> edition pg 1405</span></strong></span></span></p>",
      "correct_choice_id": 23262,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59694,
      "choices": [
        {
          "id": 238089,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Wood&#39;s lamp examination</span></span></span></p>"
        },
        {
          "id": 238090,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">KOH mount</span></span></span></p>"
        },
        {
          "id": 238091,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Skin biopsy</span></span></span></p>"
        },
        {
          "id": 238092,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bacterial culture</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 7-year-old boy is brought to the clinic by his mother due to hair loss and an itchy scalp that has been progressively worsening over the past few weeks. The mother reports that the boy first developed small, scaly patches on his scalp, which have since expanded and merged into a larger, hairless area with broken hair shafts. She noticed that the affected areas occasionally have a mild yellowish discharge, and the boy frequently scratches his head, which seems to worsen at night. The mother also reports swelling in his neck, which she assumes are &quot;swollen glands.&quot;</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The child has no significant past medical history but has recently been playing with a neighbor&rsquo;s kitten, which also seems to be losing hair. On examination, the boy has a well-demarcated, round, scaly alopecic patch on the scalp with visible broken hairs close to the scalp surface. There is mild erythema, and some pustules are visible. On palpation, there is mild tenderness, and the scalp feels boggy in the affected area. Additionally, cervical lymphadenopathy is noted on the right side.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Given the clinical findings and the mother&#39;s observations, what is the most appropriate diagnostic tool to confirm the suspected diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/03/picture2.jpg\" style=\"height:411px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q8906118",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139216,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. KOH mount</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The clinical presentation, including the scaly, hairless patch with broken hairs and associated cervical lymphadenopathy, strongly suggests tinea capitis, particularly the inflammatory type known as kerion, which is commonly seen in children. The KOH (potassium hydroxide) mount is the most appropriate diagnostic tool in this scenario. It involves scraping the affected area, placing the sample on a slide with KOH, and examining it under a microscope to visualize fungal spores and hyphae, which confirm the diagnosis of tinea capitis. This test distinguishes fungal infections like ectothrix (spores outside the hair shaft) and endothrix (spores inside the hair shaft) patterns that are characteristic of tinea capitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Wood&#39;s lamp examination</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Wood&#39;s lamp examination can help identify some fungal infections, such as those caused by Microsporum canis, which fluoresce under UV light. However, this method is less reliable because not all tinea capitis-causing fungi fluoresce, particularly Trichophyton species, which are common in this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Skin biopsy</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Skin biopsy is not a first-line test for diagnosing tinea capitis due to its invasive nature. It is generally reserved for atypical presentations where the diagnosis is unclear or when differentiating from other inflammatory scalp conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Bacterial culture</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bacterial culture is not appropriate in this case as it is used to identify bacterial pathogens, not fungal organisms. The symptoms and appearance strongly point towards a fungal etiology rather than a bacterial one.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tinea capitis, commonly seen in children, presents with scaly patches of alopecia, broken hair shafts, and sometimes boggy, inflamed areas known as kerions. The KOH mount is the preferred diagnostic method, allowing direct visualization of fungal elements. Management includes systemic antifungal medications like griseofulvin or terbinafine, with appropriate identification of the causative organism guiding therapy.</span></span></span></p>",
      "correct_choice_id": 238090,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6130,
      "choices": [
        {
          "id": 24489,
          "text": "<p><span style=\"font-size:12pt;\">B, A, C, D</span></p>"
        },
        {
          "id": 24490,
          "text": "<p><span style=\"font-size:12pt;\">B, A, D, C</span></p>"
        },
        {
          "id": 24491,
          "text": "<p><span style=\"font-size:12pt;\">B, C, A, D</span></p>"
        },
        {
          "id": 24492,
          "text": "<p><span style=\"font-size:12pt;\">B, D, A, C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Arrange the following in sequence?&nbsp;</span>(INICET NOV 2022)</p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12pt;\">Crowning</span></li><li><span style=\"font-size:12pt;\">Engagement</span></li><li><span style=\"font-size:12pt;\">Restitution</span></li><li><span style=\"font-size:12pt;\">External rotation</span></li></ol>",
      "unique_key": "Q3546784",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139217,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) B, A, C, D</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The sequence of cardinal movements in the mechanism of labor is a series of positions and motions that the fetus goes through as it navigates through the birth canal. These movements are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Engagement</strong>: This is when the fetal head enters the pelvic inlet and the widest part of the head has passed through the pelvic brim.</span></li><li><span style=\"font-size:12pt;\"><strong>Descent</strong>: The downward movement of the fetal head within the pelvic inlet.</span></li><li><span style=\"font-size:12pt;\"><strong>Flexion</strong>: The fetal head bends so the chin is brought closer to the chest, presenting the smallest diameter to the birth canal.</span></li><li><span style=\"font-size:12pt;\"><strong>Internal Rotation</strong>: The fetal head rotates to align with the maternal pelvis.</span></li><li><span style=\"font-size:12pt;\"><strong>Crowning</strong>: The fetal head is visible at the vulva without slipping back.</span></li><li><span style=\"font-size:12pt;\"><strong>Extension</strong>: The fetal head extends as it passes under the symphysis pubis.</span></li><li><span style=\"font-size:12pt;\"><strong>Restitution</strong>: The fetal head rotates to the position it was in when it engaged in the pelvis.</span></li><li><span style=\"font-size:12pt;\"><strong>External Rotation</strong>: The fetal shoulders rotate to align with the head.</span></li><li><span style=\"font-size:12pt;\"><strong>Expulsion of the rest of the body</strong>: The remainder of the fetal body is delivered.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. B, A, D, C</strong>: This sequence incorrectly places external rotation before restitution.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. B, C, A, D</strong>: This sequence incorrectly places restitution before crowning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. B, D, A, C</strong>: This sequence incorrectly places external rotation before crowning and restitution.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The cardinal movements in the mechanism of labor occur in the following sequence: engagement, descent, flexion, internal rotation, extension (preceded by crowning), restitution, external rotation, and expulsion of the rest of the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg 145</strong></span></p>",
      "correct_choice_id": 24489,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14008,
      "choices": [
        {
          "id": 55993,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinoblastoma</span></p>"
        },
        {
          "id": 55994,
          "text": "<p><span style=\"font-size:12.0pt;\">Medulloblastoma</span></p>"
        },
        {
          "id": 55995,
          "text": "<p><span style=\"font-size:12.0pt;\">Rhabdomyosarcoma</span></p>"
        },
        {
          "id": 55996,
          "text": "<p><span style=\"font-size:12.0pt;\">Astrocytoma</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 7-year-old boy presented with a white pupillary reflex for which enucleation was done. The histopathological examination of the specimen showed Flexner-Wintersteiner rosettes. What is the most likely diagnosis? (</span>NEET PG 2021)</p>",
      "unique_key": "Q9417390",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139218,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Retinoblastoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most likely diagnosis with a histopathological finding of Flexner-Wintersteiner rosettes in a 7-year-old child with a whitish pupillary reflex is retinoblastoma. Flexner-Wintersteiner rosettes refer to an arrangement of columnar cells around a central lumen, which is highly characteristic of retinoblastoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture9333.jpg\" alt=\"\" width=\"500\" height=\"481\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture10333333.jpg\" alt=\"\" width=\"300\" height=\"193\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Retinoblastoma is a malignant proliferation of immature retinal neural cells and is the most common intraocular malignancy in children.</span></li><li><span style=\"font-size:12.0pt;\">It is associated with mutations in the <strong>RB1</strong> gene at chromosome <strong>13q14</strong>.</span></li><li><span style=\"font-size:12.0pt;\">It is a tumour of a group called <strong>small round blue cell tumours</strong> because the immature retinal neural cells are seen as small round cells with large nuclei.</span></li><li><span style=\"font-size:12.0pt;\">Most common presentation is leukocoria.</span></li><li><span style=\"font-size:12.0pt;\">2nd most common symptom is squint.</span></li><li><span style=\"font-size:12.0pt;\">Clinical Features:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>i). Quiescent stage:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">Characterized by Leukocoria which is also known as Amaurotic cat’s eye appearance, convergent squint, defective vision and nystagmus (seen in bilateral cases).</span></li><li><span style=\"font-size:12.0pt;\">Ophthalmoscopically, endophytic retinoblastoma gives “cottage cheese appearance” whereas exophytic tumor present as exudative retinal detachment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>ii). Glaucomatous stage:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">Presents as severe pain, redness and watering. It may also result in hyphemia or pseudo hypopyon (contains tumor cells).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>iii). Extraocular extension:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">Globe burst through sclera near limbus and presents as marked proptosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>iv). Distant metastasis:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">Metastasis of retinoblastoma spread to</span></li><li><span style=\"font-size:12.0pt;\">Optic nerve via direct extension</span></li><li><span style=\"font-size:12.0pt;\">Pre-auricular lymph nodes via lymphatics</span></li><li><span style=\"font-size:12.0pt;\">Cranial bones via blood</span></li><li><span style=\"font-size:12.0pt;\">Microscopy – Flexner-Winter Steiner rosettes.</span></li><li><span style=\"font-size:12.0pt;\">Treatment:</span></li><li><span style=\"font-size:12.0pt;\">Enucleation</span></li><li><span style=\"font-size:12.0pt;\">Chemotherapy→ intra-arterial chemo – melphalan in ophthalmic artery is very successful.</span></li><li><span style=\"font-size:12.0pt;\">VEC is very successful:</span></li><li><span style=\"font-size:12.0pt;\">V – Vincristine</span></li><li><span style=\"font-size:12.0pt;\">E – Etoposide</span></li><li><span style=\"font-size:12.0pt;\">C – Carboplatin</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Medulloblastoma:</strong> A malignant brain tumor located in the posterior fossa, not associated with intraocular findings or leukocoria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Rhabdomyosarcoma:</strong> A soft tissue sarcoma affecting muscles, often presenting as a mass in the orbit but not causing leukocoria or associated with Flexner-Wintersteiner rosettes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Astrocytoma</strong>: A tumor of the central nervous system (glial origin), which does not occur intraocularly and is not linked with Flexner-Wintersteiner rosettes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Flexner-Wintersteiner rosettes are a hallmark of retinoblastoma, indicating a malignant proliferation of immature retinal neural cells. This specific histopathological finding is crucial for diagnosing retinoblastoma, especially in children presenting with leukocoria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Different rosettes seen in retinoblastoma:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. True rosette -FLEXNER-WINTERSTEINER ROSETTE</span></p><ul><li><span style=\"font-size:12.0pt;\">This is specific for RB - hallmark of RB</span></li><li><span style=\"font-size:12.0pt;\">It consists of tumor cells surrounding a central lumen that contains cytoplasmic extensions from the tumor cells, which have well-differentiated features suggestive of primitive photoreceptor cells.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">2. HOMER-WRIGHT ROSETTE is a non-specific rosette seen in any of the primitive neuroectodermal tumors. Tumor cells surround a central region containing neutrophil.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">3. FLUERETTE is pseudo rosette because the central structure is not a part of the tumor and it consists of tumor cells around a blood vessel.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/whatsapp-image-2023-11-10-at-174623-1.jpeg\" alt=\"\" width=\"700\" height=\"404\"></p>",
      "correct_choice_id": 55993,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11101,
      "choices": [
        {
          "id": 44370,
          "text": "<p><span style=\"font-size:18px;\">Soiled linen bedsheet</span></p>"
        },
        {
          "id": 44371,
          "text": "<p><span style=\"font-size:18px;\">Glove paper cover</span></p>"
        },
        {
          "id": 44372,
          "text": "<p><span style=\"font-size:18px;\">Gloves</span></p>"
        },
        {
          "id": 44373,
          "text": "<p><span style=\"font-size:18px;\">Contaminated gloves</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>During your clinical rotation, you notice the different color-coded waste bins meticulously arranged by the nursing staff as per the hospital's waste management protocol. If you were to guide a new intern about the appropriate disposal of items, which item among the following would you instruct them to discard in the black bin? [</strong><i><strong>INICET MAY 2021]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip21.jpg\" alt=\"\" width=\"400\" height=\"215\"></strong></span></p>",
      "unique_key": "Q2203105",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139219,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Glove paper cover</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The paper cover for gloves constitutes regular solid waste, which should be placed in the designated black bin.</span></li><li><span style=\"font-size:18px;\">All types of non-infectious general refuse, including food waste, paper waste, and mineral water bottles, ought to be deposited in the black bins.</span></li><li><span style=\"font-size:18px;\">Bedsheets and linens that are soiled and contaminated with blood or bodily fluids should be appropriately disposed of in the yellow bin.</span></li><li><span style=\"font-size:18px;\">Plastic materials that are recyclable, such as gloves and contaminated gloves, should be placed in the red bins.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Soiled linen bedsheet:</strong> Should be disposed of in the yellow bin for contaminated waste.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Gloves:</strong> Should be placed in the red bin for recyclable materials.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Contaminated gloves:</strong> Also go in the red bin for medical waste.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Non-infectious general refuse, such as glove paper covers, should be discarded in the black bin.</span></li></ul>",
      "correct_choice_id": 44371,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3449,
      "choices": [
        {
          "id": 13775,
          "text": "<p><span style=\"font-size:12.0pt;\">P. vivax</span></p>"
        },
        {
          "id": 13776,
          "text": "<p><span style=\"font-size:12.0pt;\">P. falciparum</span></p>"
        },
        {
          "id": 13777,
          "text": "<p><span style=\"font-size:12.0pt;\">Filariasis</span></p>"
        },
        {
          "id": 13778,
          "text": "<p><span style=\"font-size:12.0pt;\">Leishmania</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Transmission assessment survey is carried out for: (INICET MAY 2019)</span></p>",
      "unique_key": "Q6322120",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139220,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Filariasis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Transmission assessment survey is carried out for filariasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lymphatic filariasis (LF) is targeted for global elimination through treatment of entire at-risk populations with repeated annual mass drug administration (MDA). Essential for program success is defining and confirming the appropriate endpoint for MDA when transmission is presumed to have reached a level low enough that it cannot be sustained even in the absence of drug intervention. Guidelines advanced by WHO call for a transmission assessment survey (TAS) to determine if MDA can be stopped within an LF evaluation unit (EU) after at least five effective rounds of annual treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. P. vivax</strong>: Transmission assessment surveys are not typically used for evaluating the transmission of <i>Plasmodium vivax</i>, which causes malaria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. P. falciparum</strong>: Transmission assessment surveys are not typically used for evaluating the transmission of <i>Plasmodium falciparum</i>, another cause of malaria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Leishmania</strong>: Transmission assessment surveys are not used for <i>Leishmania</i> species, which cause leishmaniasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Transmission Assessment Surveys (TAS) are essential tools used to evaluate the success of mass drug administration programs for lymphatic filariasis and determine if the transmission levels are low enough to discontinue these programs.</span></p>",
      "correct_choice_id": 13777,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16057,
      "choices": [
        {
          "id": 64188,
          "text": "<p><span style=\"font-size:12.0pt;\">III</span></p>"
        },
        {
          "id": 64189,
          "text": "<p><span style=\"font-size:12.0pt;\">VII</span></p>"
        },
        {
          "id": 64190,
          "text": "<p><span style=\"font-size:12.0pt;\">IV</span></p>"
        },
        {
          "id": 64191,
          "text": "<p><span style=\"font-size:12.0pt;\">VI</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the cranial nerve passing through the given structure: (</span>INICET Nov 2021)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/ai-16.jpg\" alt=\"\" width=\"286\" height=\"333\"></span></p>",
      "unique_key": "Q9761305",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139221,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. IV</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the given image, the dorsal aspect of the brainstem is marked and the cranial nerve that is passing there is the trochlear nerve (CN IV).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Trochlear nerve</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Origin</strong> : The trochlear nerve is the only cranial nerve that emerges from the dorsal (posterior) aspect of the brain. Specifically, it originates from the dorsal surface of the midbrain, below the inferior colliculus.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Exit </strong>proceed to the superior orbital fissure to enter the orbit.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: It is a motor nerve that innervates a single extraocular muscle, the superior oblique muscle. The primary action of the superior oblique muscle is to intort (rotate inward), depress, and abduct the eyeball.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Oculomotor Nerve (III):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Origin</strong>: The oculomotor nerve originates in the anterior aspect of the midbrain. Specifically, its fibers arise from the oculomotor nucleus, which is located in the superior colliculus of the midbrain.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Exit Point</strong>: After emerging from the midbrain, it exits the brainstem at the level of the interpeduncular fossa (the space between the cerebral peduncles).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: It innervates most of the muscles controlling eye movements. It also contains parasympathetic fibers that are involved in pupil constriction and the lens's accommodation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Facial Nerve (VII):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Origin</strong>: The facial nerve arises from the pons. Specifically, its fibers come from the facial nerve nucleus.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Exit Point</strong>: It emerges from the brainstem at the cerebellopontine angle, between the pons and the medulla. It exits lateral to the abducens nerve and medial to the vestibulocochlear nerve (VIII).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: The facial nerve controls the muscles of facial expression. It also has taste fibers from the anterior two-thirds of the tongue and carries parasympathetic fibers to salivary and lacrimal glands.</span><br>&nbsp;</li></ul><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Abducens Nerve (VI):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Origin</strong>: The abducens nerve originates in the pons. Its fibers arise from the abducens nucleus, which is located in the dorsal pons near the floor of the fourth ventricle.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Exit Point</strong>: It emerges from the ventral surface of the brainstem at the junction between the pons and the medulla, in the groove between the pons and the pyramid of the medulla.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: It innervates the lateral rectus muscle, which abducts the eye.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The trochlear nerve is the fourth cranial nerve that originates in the midbrain at the level of the inferior colliculus from the trochlear nuclei. It is the only cranial nerve that emerges from the brainstem's dorsal surface and has the longest intracranial course.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The main actions of superior oblique are:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Depression in adducted position- Patients with trochlear nerve palsy have difficulty in looking downwards when eyes are in the adducted position.</span></li><li><span style=\"font-size:12.0pt;\">Abduction</span></li><li><span style=\"font-size:12.0pt;\">Intorsion of the eyeball.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-194331.JPG\" alt=\"\" width=\"1000\" height=\"471\"></span></p>",
      "correct_choice_id": 64190,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15614,
      "choices": [
        {
          "id": 62416,
          "text": "<p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis</span></p>"
        },
        {
          "id": 62417,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteoarthritis</span></p>"
        },
        {
          "id": 62418,
          "text": "<p><span style=\"font-size:12.0pt;\">Psoriatic arthropathy</span></p>"
        },
        {
          "id": 62419,
          "text": "<p><span style=\"font-size:12.0pt;\">Jaccoud arthropathy</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Involvement of PIP, DIP and 1st CMC with sparing of wrist and MCP is seen in:&nbsp;(NEET PG 2020)</span></p>",
      "unique_key": "Q8276915",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139222,
      "difficulty_level": "intermediate",
      "subjects_id": [
        15
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Osteoarthritis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Osteoarthritis characteristically involves distal interphalangeal joint (Heberden’s node), proximal interphalangeal joint (Bouchard’s node), 1st carpometacarpal joint (base of thumb) of hand.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/03/18.jpg\" alt=\"\" width=\"500\" height=\"384\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Sparing of wrist and MCP is a feature of Osteoarthritis.</span></li><li><span style=\"font-size:12.0pt;\">Rheumatoid Arthritis spares DIP and involves PIP, MCP and Wrist.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Diseases And Usual Joints Affected:</strong></span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/03/screenshot-2024-01-03-125216.jpg\" alt=\"\" width=\"1000\" height=\"829\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Characteristic Joint involvement in HANDS in various Arthritis:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/03/screenshot-2024-01-03-130158.jpg\" alt=\"\" width=\"1000\" height=\"436\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/03/19.jpg\" alt=\"\" width=\"500\" height=\"385\"></strong></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The hand (to diagnose arthritis)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Rheumatoid arthritis</strong>. Commonly Involved Joints (14 joints are used for diagnosis according to 1987 criterion – Right or left side) are Wrist joint, Metacarpophalangeal (MCP) joint, Proximal interphalangeal (PIP) joint, Elbow joint, Knee joint, Ankle joint, and Metatarsophalangeal joint. Less Commonly Involved joints are Upper cervical spine (facet joint) with Atlantoaxial subluxation, Hip joint, Temporomandibular joint, Subtalar and forefoot joints. Usually, DIP is not involved but is involved when swan neck and boutonniere deformity develops. The involvement in late stages is due to the pull of tendons/soft tissues in these deformities. Lumbar Spine is Usually Spared in RA.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/03/20_WkQrkMY.jpg\" alt=\"\" width=\"600\" height=\"233\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/03/22_5EuTrTC.jpg\" alt=\"\" width=\"400\" height=\"629\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Psoriatic arthropathy</strong>. Five patterns of joint involvement are seen: <strong>Arthritis of DIP joint, </strong>Asymmetrical oligoarthritis, Symmetrical polyarthritis, Axial involvement (spine and sacroiliac joint), and Arthritis mutilans. Nail changes occurs in 90% patients of psoriatic arthritis. Dactylitis, enthesitis and tenosynovitis are also common <strong>Shortening of digitis (telescoping), because of underlying osteolysis is characteristic of psoriatic arthritis. </strong>Fibrous and bony ankylosis of small joints (greater tendency than RA). Almost any peripheral joint can be involved. <strong>Radiological Features includes </strong>classical <strong>pencil cup deformity of DIP joints.</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/03/23.jpg\" alt=\"\" width=\"300\" height=\"212\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Pencil-in-cup deformity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Jaccoud arthropathy</strong>. It typically affects MCP joints but can also affect PIP joints of the hand, wrist joint and knee joint. It is a deforming non-erosive arthropathy characterized by ulnar deviation of 2<sup>nd</sup>-5<sup>th</sup> fingers with MCP joint subluxation.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/03/24.jpg\" alt=\"\" width=\"300\" height=\"365\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Involvement of PIP, DIP and 1st CMC with sparing of wrist and MCP is seen in osteoarthritis.</span></li></ul>",
      "correct_choice_id": 62417,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13947,
      "choices": [
        {
          "id": 55749,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cholesterolosis</span></span></span></p>"
        },
        {
          "id": 55750,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Strawberry gallbladder</span></span></span></p>"
        },
        {
          "id": 55751,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gallbladder polyps</span></span></span></p>"
        },
        {
          "id": 55752,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gallbladder carcinoma</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the condition shown in the picture: (</span></span>AIIMS May 2017)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Helvetica Neue&quot;\"><span style=\"color:black\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-85_tXtUv3X.jpg\" style=\"height:443px; width:315px\" /></span></span></span></span></p>",
      "unique_key": "Q1785702",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139243,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Gallbladder polyp </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The image depicts a gallbladder with a lesion that is characteristic of a gallbladder polyp. Gallbladder polyps are mucosal protrusions into the gallbladder lumen. They are typically benign but can have malignant potential depending on their size and other risk factors. The appearance of the polyp in the image suggests it is non-invasive, indicated by the localized growth without invasion into the surrounding gallbladder wall or beyond. This finding is consistent with a benign polyp rather than gallbladder carcinoma, which would typically show more extensive invasion and might require more aggressive surgical resection including parts of the liver and regional lymph nodes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Cholesterolosis:</strong>&nbsp;Often manifests as a stippled or strawberry appearance of the gallbladder wall due to lipid deposits, not as distinct polypoid protrusions. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Strawberry gallbladder:</strong>&nbsp;A term more commonly associated with cholesterolosis; it does not generally present as discrete polyps. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Gallbladder carcinoma:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Typically would involve more aggressive features and more extensive surgical intervention reflecting invasive disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Understand the characteristics and presentation of gallbladder polyps, distinguishing them from other gallbladder conditions such as cholesterolosis, strawberry gallbladder, and carcinoma based on imaging and surgical findings.</span></span></span></p>",
      "correct_choice_id": 55751,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59695,
      "choices": [
        {
          "id": 238093,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Allergic Contact Dermatitis</span></span></span></p>"
        },
        {
          "id": 238094,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dermatitis Artefacta</span></span></span></p>"
        },
        {
          "id": 238095,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Impetigo</span></span></span></p>"
        },
        {
          "id": 238096,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erythema Multiforme</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 10-year-old girl is brought to the dermatologist by her mother due to unusual lesions on her face, as shown in the image. The lesions appeared suddenly after the child applied henna during a school event. The mother reports that this has happened before with other skin products, but the child denies any pain or itching and is generally evasive about how the lesions occurred. What is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/03/picture5.jpg\" style=\"height:285px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q2595374",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139245,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. Dermatitis Artefacta</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dermatitis artefacta is a psychodermatological condition in which patients deliberately inflict skin lesions on themselves, often due to underlying psychological stress or disorders. This condition is common in individuals seeking attention or expressing psychological distress through physical means. The lesions are typically well-defined, unusual in shape or pattern, and located in accessible areas that the patient can easily reach, such as the face, arms, or legs. In this case, the linear pattern of lesions and the child&#39;s vague and evasive responses are classic indications of dermatitis artefacta, rather than a true allergic or infectious skin condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Allergic Contact Dermatitis</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Allergic contact dermatitis occurs due to an allergic reaction to an external substance, such as henna. Lesions are typically pruritic and present as eczematous eruptions, usually localized to the area of contact. However, the psychological pattern and non-pruritic nature seen in this case do not align with allergic contact dermatitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Impetigo</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Impetigo is a bacterial skin infection that typically presents with honey-colored crusts, often around the nose and mouth. The lesions are not self-inflicted and are usually due to bacterial colonization following minor trauma. The pattern in the image does not fit impetigo.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Erythema Multiforme</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Erythema multiforme is a hypersensitivity reaction often triggered by infections or drugs, presenting with target lesions, not linear or deliberately patterned plaques. It involves the palms, soles, and mucous membranes, which are not evident in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dermatitis artefacta is a condition where patients inflict lesions on themselves, often in patterns that reflect the psychological underpinnings of the behavior. It is crucial to recognize this pattern, especially in young patients, and approach with psychological support and appropriate referrals rather than purely dermatologic treatment.</span></span></span></p>",
      "correct_choice_id": 238094,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13760,
      "choices": [
        {
          "id": 55001,
          "text": "<p><span style=\"font-size:12.0pt;\">Pineal gland</span></p>"
        },
        {
          "id": 55002,
          "text": "<p><span style=\"font-size:12.0pt;\">Falx cerebri</span></p>"
        },
        {
          "id": 55003,
          "text": "<p><span style=\"font-size:12.0pt;\">Fornix</span></p>"
        },
        {
          "id": 55004,
          "text": "<p><span style=\"font-size:12.0pt;\">Pituitary gland</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the structure marked in the image given below: (</span>NEET PG 2019)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_U7y8W2J.png\" width=\"225\" height=\"154\"></p><p>&nbsp;</p>",
      "unique_key": "Q5921565",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139246,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Fornix</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The image given shows a midsagittal section of the brain.</span></li><li><span style=\"font-size:12.0pt;\">The structure marked is the Fornix.</span></li><li><span style=\"font-size:12.0pt;\">The fornix is a C-shaped bundle of white matter located in the medial surface of the brain, just below the corpus callosum.</span></li><li><span style=\"font-size:12.0pt;\">The fornix is an important part of the limbic system, and it is the hippocampus's largest single pathway, connecting it to various subcortical structures.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/untitled-929_uEznJqc.jpg\" alt=\"\" width=\"700\" height=\"439\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Pineal gland</strong>: It is a small endocrine gland located in a midsagittal section, seen as a small structure located posterior to the third ventricle in the midline, projecting from the diencephalon. Its main hormone, melatonin, plays a critical role in the regulation of circadian rhythms, influencing sleep-wake cycles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Falx cerebri</strong>: It is a dural fold that descends vertically in the longitudinal fissure, which divides the cerebral hemispheres. In a midsagittal view, it appears as a thin membrane running vertically between the left and right cerebral hemispheres. The falx cerebri attaches anteriorly to the crista galli of the ethmoid bone and posteriorly to the internal occipital protuberance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Pituitary gland</strong>: It is often referred to as the \"master gland\", is an endocrine gland responsible for producing several critical hormones that regulate growth, blood pressure, and other functions. In the midsagittal view, the pituitary gland is located at the base of the brain, hanging down from a stalk (infundibulum) from the hypothalamus. This gland rests within a depression in the sphenoid bone called the sella turcica.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Fornix</strong> is a C-shaped bundle of nerve fibers that acts as a major output tract from the hippocampus to the mammillary bodies and then onto the thalamus. In the midsagittal section, the fornix is seen as an arching structure that lies inferior to the corpus callosum, the massive fiber tract connecting the two cerebral hemispheres. The body of the fornix travels anteriorly and inferiorly, eventually dividing into left and right columns which curve downward in front of the thalamus.</span></p>",
      "correct_choice_id": 55003,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14345,
      "choices": [
        {
          "id": 57341,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemoglobin falls from 11g% to 10g%</span></p>"
        },
        {
          "id": 57342,
          "text": "<p><span style=\"font-size:12.0pt;\">Extraperitoneal bladder rupture</span></p>"
        },
        {
          "id": 57343,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumoperitoneum</span></p>"
        },
        {
          "id": 57344,
          "text": "<p><span style=\"font-size:12.0pt;\">Distended gallbladder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What sign on day 2 would indicate a need for surgery in a patient who was conservatively managed in the ICU after grade 3 splenic trauma? &nbsp;</span><span style=\"font-size:11.0pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
      "unique_key": "Q8513845",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139247,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Pneumoperitoneum</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of pneumoperitoneum on imaging would indicate a need for laparotomy as it suggests visceral perforation, which can lead to secondary peritonitis. Conservative management is usually recommended for splenic trauma, and surgical management is reserved for cases of hemodynamic instability or failure to respond to conservative management. Splenic angiography and embolization are also used for non-surgical management. The severity of splenic injury is graded by the AST spleen injury scale, and abdominal CT with intravenous contrast is the preferred investigation. A drop of 1g% of hemoglobin may be a physiological finding, and would not warrant a surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Extraperitoneal bladder rupture can be managed with a urinary catheter, while distended gall bladder is a normal finding if patient has been nil per oral.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Grades of splenic trauma based on the American Association for the Surgery of Trauma (AAST) spleen injury scale:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/20/screenshot-2024-07-20-123251.png\" alt=\"\" width=\"1000\" height=\"296\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pneumoperitoneum, the presence of air in the abdominal cavity, is a concerning sign and typically indicates a perforation of the gastrointestinal tract or another abdominal organ. In a patient with grade 3 splenic trauma, the development of pneumoperitoneum suggests a concomitant hollow viscous perforation and would likely necessitate surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hemoglobin falls from 11g% to 10g%</strong>: A drop in hemoglobin levels can be indicative of ongoing bleeding but may not be an immediate indication for surgery. It would typically be monitored closely, and the need for surgery would depend on the rate of decline and the overall clinical condition of the patient. Typically, a decline by &gt;2g% Hb is suggestive of active bleed and warrants further management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Extraperitoneal bladder rupture</strong>: While extraperitoneal bladder rupture is a serious condition, it is not directly related to splenic trauma. Its management involves keeping a per urethral Foleys and allowing the rupture to heal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Distended Gall bladder</strong>: This is a normal physiological finding and does not mandate surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pneumoperitoneum is the most concerning sign in a patient with grade 3 splenic trauma and would indicate a need for surgery, as it suggests a perforation.</span></p>",
      "correct_choice_id": 57343,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10038,
      "choices": [
        {
          "id": 40118,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rosai-Dorfman disease</span></span></span></p>"
        },
        {
          "id": 40119,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Kimura disease</span></span></span></p>"
        },
        {
          "id": 40120,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Langerhans cell histiocytosis</span></span></span></p>"
        },
        {
          "id": 40121,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Juvenile Xanthogranuloma</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 7-year-old child brought to OPD with complaints of fever, erythematous rash, and bone pain. X-ray of the skull revealed multiple lytic lesions. Skin biopsy shows prominent nuclear grooves with eosinophils as in the image below. Immunohistochemistry is positive for S100, CD1a. What is the likely diagnosis?&nbsp;&nbsp;(INICET NOV 2022)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture10.jpg\" style=\"height:264px; width:300px\" /></p>",
      "unique_key": "Q1150000",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139248,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Langerhans cell histiocytosis</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The above history along with the histopathological image showing Langerhans cells (image A), <strong>CD1a and positive S100 positive, is suggestive of Langerhans cell histiocytosis (LCH).</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-134845.jpg\" style=\"height:493px; width:1000px\" /></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other option:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Rosai Dorfman disease</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Rosai Dorfman disease doesn&rsquo;t show histiocytes. It presents with painless lymphadenopathy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Kimura disease</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Kimura disease presents with painless lymphadenopathy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Juvenile Xanthogranuloma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Juvenile Xanthogranuloma shows multinucleated giant cells. It presents with papular lesions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective</span></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Langerhans cell histiocytosis (LCH)</span></strong><span style=\"font-size:12.0pt\"> is identified by a combination of clinical symptoms (such as bone pain, fever, and rash), characteristic histopathological features (nuclear grooves, eosinophils), and positive immunohistochemical markers (S100, CD1a). The presence of multiple lytic bone lesions, especially in the skull, is a key diagnostic clue.</span></span></span></p>",
      "correct_choice_id": 40120,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7075,
      "choices": [
        {
          "id": 28268,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">30 minutes</span></span></span></p>"
        },
        {
          "id": 28269,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">60 minutes</span></span></span></p>"
        },
        {
          "id": 28270,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">90 minutes</span></span></span></p>"
        },
        {
          "id": 28271,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">120 minutes</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient is on phenytoin for a seizure disorder. He was prescribed sucralfate 4 times a day for peptic ulcers. What should be the minimum duration of time between consumption of these drugs? (</span></span>INICET May 2021)</p>",
      "unique_key": "Q7671466",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139249,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. 120 minutes</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sucralfate is made up of aluminium octosulphate of sucrose. In the acidic pH of the stomach, it gets polymerized into a viscous fluid which adheres to the base of the ulcer for upto 6 hours. However, this viscous layer prevents the absorption of other drugs like phenytoin, ketoconazole, fluoroquinolones etc. from the stomach. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When a patient is taking both phenytoin (an antiepileptic drug) and sucralfate (a medication used to treat peptic ulcers), it&#39;s important to manage the timing of these medications to avoid drug interactions. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sucralfate can interfere with the absorption of phenytoin when taken too closely together, leading to reduced effectiveness of phenytoin.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The general recommendation is to separate the administration of these two drugs by at least 2 hours. This separation allows sufficient time for the phenytoin to be absorbed before the sucralfate is taken, which can bind to drugs in the gastrointestinal tract and hinder their absorption.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The minimum duration of time between the consumption of phenytoin and sucralfate should be at least 120 minutes (2 hours) to ensure that phenytoin is adequately absorbed and to avoid interactions that could reduce its effectiveness.</span></span></span></p>",
      "correct_choice_id": 28271,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7139,
      "choices": [
        {
          "id": 28524,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amiodarone</span></span></span></span></span></p>"
        },
        {
          "id": 28525,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Amlodipine</span></span></span></span></span></p>"
        },
        {
          "id": 28526,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Metoprolol</span></span></span></span></span></p>"
        },
        {
          "id": 28527,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Verapamil</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 57-year-old man was brought to the hospital with complaints of dizziness and breathlessness. During his physical examination, you notice the following discoloration over his face. He is presently being treated with amiodarone, metoprolol, verapamil, lisinopril, and amlodipine. Which of the following drugs is most likely responsible? (</span></span></span>INICET Nov 2021)</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/789.jpg\" style=\"height:272px; width:250px\" /></span></span></span></span></p>",
      "unique_key": "Q7086046",
      "question_audio": null,
      "question_video": null,
      "map_id": 13139250,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Amiodarone </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amiodarone&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is known to cause skin discoloration, which can appear as a bluish or greyish hue, especially on areas exposed to the sun. This effect is due to the drug&#39;s deposition in the skin and can occur after prolonged use. Amiodarone-induced skin discoloration (also known as ceruloderma or blue man syndrome) is the most likely cause of the bluish discoloration in this patient&#39;s case.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Amlodipine</strong>: A calcium channel blocker used to treat hypertension and angina. Skin discoloration is not a common side effect of amlodipine.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Metoprolol</strong>: A beta-blocker used for various heart conditions, including hypertension and arrhythmias. Metoprolol is not typically associated with skin discoloration.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Verapamil</strong>: Another calcium channel blocker used for hypertension, angina, and certain arrhythmias. Like amlodipine, it is not commonly associated with causing skin discoloration.</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amiodarone can cause a characteristic bluish or greyish discoloration of the skin, particularly in sun-exposed areas, due to its deposition in the skin after prolonged use. This side effect is not commonly associated with the other medications listed (amlodipine, metoprolol, and verapamil).</span></span></span></span></p>",
      "correct_choice_id": 28524,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5919,
      "choices": [
        {
          "id": 23646,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partial mole</span></span></span></p>"
        },
        {
          "id": 23647,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Choriocarcinoma</span></span></span></p>"
        },
        {
          "id": 23648,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placental site trophoblastic tumor</span></span></span></p>"
        },
        {
          "id": 23649,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Invasive mole</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational trophoblastic neoplasm does not include?&nbsp;</span></span>(NEET PG 2019)</p>",
      "unique_key": "Q2288941",
      "question_audio": null,
      "question_video": null,
      "map_id": 13321423,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Partial mole </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational trophoblastic disease (GTD) includes a spectrum of conditions characterized by abnormal trophoblastic proliferation. These conditions are broadly classified into molar and non-molar trophoblastic diseases.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydatidiform Mole:</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Complete Mole</span></strong></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partial Mole</span></strong></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Invasive Mole</span></strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-Molar Trophoblastic Diseases:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Choriocarcinoma</span></strong></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placental Site Trophoblastic Tumor</span></strong></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epithelioid Trophoblastic Tumor</span></strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational Trophoblastic Neoplasia (GTN)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, on the other hand, includes only the malignant forms of trophoblastic disease:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Invasive Mole</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Choriocarcinoma</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placental Site Trophoblastic Tumor</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epithelioid Trophoblastic Tumor</span></strong></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>partial mole</strong> is a type of hydatidiform mole and is considered benign. It is not included under GTN as it does not have malignant potential unless it transforms into an invasive mole, which is rare.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Choriocarcinoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a malignant form of GTD and is classified under GTN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Placental Site Trophoblastic Tumor</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is another malignant form of GTD and is included under GTN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Invasive Mole</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: An invasive mole is a malignant transformation of a hydatidiform mole and is included under GTN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partial moles are not classified as gestational trophoblastic neoplasia (GTN) because they are generally benign and non-malignant.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 615, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23646,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11115,
      "choices": [
        {
          "id": 44426,
          "text": "<p><span style=\"font-size:18px;\">Do not give DPT</span></p>"
        },
        {
          "id": 44427,
          "text": "<p><span style=\"font-size:18px;\">Restart DPT</span></p>"
        },
        {
          "id": 44428,
          "text": "<p><span style=\"font-size:18px;\">Give second dose of DPT</span></p>"
        },
        {
          "id": 44429,
          "text": "<p><span style=\"font-size:18px;\">Give dT alone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A physician is consulting with a mother who has brought her one-year-old child to a health clinic. The mother mentions that the child received the initial DPT vaccine dose at 6 weeks but has not received any subsequent vaccinations. What would be the most appropriate next step in this child's immunization schedule? </strong><i><strong>[INICET MAY 2022]</strong></i></span></p>",
      "unique_key": "Q3522123",
      "question_audio": null,
      "question_video": null,
      "map_id": 13321424,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Give second dose of DPT</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">If there is delayed immunization in DPT doses, there is no need to repeat the schedule from the start, just continue the schedule.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Age Limits for Delayed Immunization in NIS, India</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-104816.png\" alt=\"\" width=\"1000\" height=\"594\"></strong></span></p>",
      "correct_choice_id": 44428,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6065,
      "choices": [
        {
          "id": 24230,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spiral artery by villous trophoblasts</span></span></span></p>"
        },
        {
          "id": 24231,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radial artery by cytotrophoblasts</span></span></span></p>"
        },
        {
          "id": 24232,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spiral artery by extravillous trophoblasts</span></span></span></p>"
        },
        {
          "id": 24233,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arcuate artery by extravillous trophoblasts</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pregnant woman with no other comorbid conditions develops preeclampsia. She enquires about the cause of her condition. The doctor explains that it is due to the failure of the invasion of? </span></span>(NEET PG 2022)</p>",
      "unique_key": "Q5888603",
      "question_audio": null,
      "question_video": null,
      "map_id": 13321425,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Spiral artery by extravillous trophoblasts </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Preeclampsia occurs due to the failure of the invasion of extravillous trophoblasts into the spiral artery.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The spiral artery supplies blood to the endometrium. In normal pregnancy, there is an invasion of the extravillous trophoblasts (specifically, endovascular trophoblasts) into the walls of the spiral arteries.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This process takes place in two waves:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">First wave (10-12 weeks):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Endovascular trophoblasts invade up to the decidual segments.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Second wave (16-18 weeks):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Endovascular trophoblasts invade up to the myometrial segments.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This invasion results in the distension of the spiral arterioles, transforming them into a low-resistance, low-pressure, and high-flow system.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In preeclampsia, the failure of the second wave of endovascular trophoblastic invasion into uterine vessels leads to decreased placental perfusion.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Spiral artery by villous trophoblasts:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Villous trophoblasts are involved in the formation of the placental villi, but they do not invade the spiral arteries.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Radial artery by cytotrophoblasts:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The radial arteries supply the deeper layers of the myometrium and are not primarily involved in the pathogenesis of preeclampsia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Arcuate artery by extravillous trophoblasts:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The arcuate arteries are part of the uterine arterial system, but their invasion by trophoblasts is not relevant to the development of preeclampsia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Preeclampsia is caused by the failure of extravillous trophoblasts to invade the spiral arteries, leading to decreased placental perfusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 1818, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 24232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13782,
      "choices": [
        {
          "id": 55089,
          "text": "<p><span style=\"font-size:12.0pt;\">3rd arch</span></p>"
        },
        {
          "id": 55090,
          "text": "<p><span style=\"font-size:12.0pt;\">4th arch</span></p>"
        },
        {
          "id": 55091,
          "text": "<p><span style=\"font-size:12.0pt;\">5th arch</span></p>"
        },
        {
          "id": 55092,
          "text": "<p><span style=\"font-size:12.0pt;\">6th arch</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The long left recurrent laryngeal nerve is due to the persistence of which embryonic pharyngeal arch artery?&nbsp;(NEET PG 2020)</span></p>",
      "unique_key": "Q6778164",
      "question_audio": null,
      "question_video": null,
      "map_id": 13321426,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. 6th arch</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The long left recurrent laryngeal nerve is due to the persistence of the left 6th arch artery.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">During embryonic development, the aortic arches give rise to several structures in the neck and chest.</span></li><li><span style=\"font-size:12.0pt;\">The 6th arch artery, which is present on both the right and left sides, gives rise to the pulmonary arteries and the ductus arteriosus.</span></li><li><span style=\"font-size:12.0pt;\">As the arch arteries regress and are replaced by the adult structures, the recurrent laryngeal nerves, which innervate the muscles of the larynx, become trapped behind the great vessels.</span></li><li><span style=\"font-size:12.0pt;\">The distal 6th arch artery vanishes on the right side. The right recurrent laryngeal nerve is caught under the 4th arch artery, which becomes the future right subclavian artery, because there is no 5th arch artery.</span></li><li><span style=\"font-size:12.0pt;\">On the left side, the 6th arch artery persists, which develops into ductus arteriosus, which later forms ligamentum arteriosum.</span></li><li><span style=\"font-size:12.0pt;\">Due to the persistence of the 6th arch artery, the left recurrent laryngeal nerve is caught under it and therefore, has a relatively long course.</span></li><li><span style=\"font-size:12.0pt;\">The left recurrent laryngeal nerve loops around the aortic arch on its way to the larynx.</span></li><li><span style=\"font-size:12.0pt;\">In the case of the long left recurrent laryngeal nerve, the nerve passes inferior to the ligamentum arteriosum, which is a remnant of the ductus arteriosus that is derived from the 6th arch artery.</span></li><li><span style=\"font-size:12.0pt;\">&nbsp;This can lead to an increased risk of injury to the nerve during surgical procedures involving the thorax or neck.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/untitled-881.jpg\" alt=\"\" width=\"500\" height=\"546\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 3rd arch</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Derivative</strong>: The 3rd pharyngeal arch artery contributes to the formation of the common carotid arteries and the proximal part of the internal carotid arteries.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relation to the recurrent laryngeal nerve</strong>: It is not directly related to the course of the recurrent laryngeal nerve, and therefore, its persistence or anomalies don't affect the recurrent laryngeal nerve's course.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 4th arch</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Derivative</strong>: The 4th pharyngeal arch artery contributes to the formation of the left side into the arch of the aorta and on the right side into the right subclavian artery.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relation to the recurrent laryngeal nerve</strong>: The recurrent laryngeal nerve, which arises from the vagus nerve, initially descends and then ascends around the 4th arch artery. However, this is not responsible for the long course of the left recurrent laryngeal nerve.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 5th arch</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Derivative</strong>: Interestingly, in many cases, the 5th pharyngeal arch artery is rudimentary or even absent in humans. When present, it doesn't form any significant structures in the mature circulatory system.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relation to the recurrent laryngeal nerve</strong>: Given its rudimentary nature, the 5th arch artery doesn't have a defined relationship with the recurrent laryngeal nerve.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The 6th pharyngeal arch artery contributes to the formation of the pulmonary arteries and the ductus arteriosus on the left side.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Relation to the recurrent laryngeal nerve</strong>: The left recurrent laryngeal nerve hooks under the ductus arteriosus (derived from the left 6th arch artery). In evolutionary terms, as the heart descended and the neck elongated during development, the nerve remained hooked around this artery, leading to its longer course on the left side. On the right side, the nerve hooks under the right subclavian artery (which isn't directly derived from the 6th arch but is related to its positioning). If there were a right-sided aortic arch (a rare congenital anomaly), the right recurrent laryngeal nerve would also have a longer course, similar to the left.</span></p>",
      "correct_choice_id": 55092,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2097,
      "choices": [
        {
          "id": 8377,
          "text": "<p><span style=\"font-size:12.0pt;\">Only b is correct</span></p>"
        },
        {
          "id": 8378,
          "text": "<p><span style=\"font-size:12.0pt;\">If a and c are correct</span></p>"
        },
        {
          "id": 8379,
          "text": "<p><span style=\"font-size:12.0pt;\">If a, b and c are correct</span></p>"
        },
        {
          "id": 8380,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b, c, &amp; d are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is correctly matched?</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">Oxygen: Simple Diffusion</span></li><li><span style=\"font-size:12.0pt;\">Glucose: facilitated diffusion</span></li><li><span style=\"font-size:12.0pt;\">Na-dependent Calcium: Active transport</span></li><li><span style=\"font-size:12.0pt;\">Na: Secondary Active transport</span></li></ol>",
      "unique_key": "Q2658137",
      "question_audio": null,
      "question_video": null,
      "map_id": 13321427,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) a, b, c, &amp; d are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;Oxygen: Simple Diffusion:&nbsp;</strong>Oxygen is transported by simple passive diffusion based on the concentration gradient. This process does not require any energy input and relies on the natural movement of oxygen molecules from an area of higher concentration to an area of lower concentration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Glucose: facilitated diffusion:&nbsp;</strong>Glucose is transported by facilitated diffusion using glucose transporters (GLUTs) and also through Na-dependent transport using sodium-glucose co-transporters (SGLT). GLUTs facilitate glucose transport without energy, while SGLT uses the sodium gradient to transport glucose into cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong>&nbsp;<strong>Na-dependent Calcium: Active transport:&nbsp;</strong>Calcium is transported by active transport mechanisms, which require energy. These mechanisms include:</span></p><ol><li><span style=\"font-size:12.0pt;\">Plasma membrane Ca2+ ATPase (PMCA), which pumps calcium out of the cell.</span></li><li><span style=\"font-size:12.0pt;\">Sodium-calcium exchanger (NCX), which exchanges intracellular calcium for extracellular sodium. Additionally, calcium can be transported via receptor-mediated mechanisms, such as the IP3 receptor, facilitating calcium transport from the smooth endoplasmic reticulum (SER) to the mitochondria.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Na: Secondary Active transport:&nbsp;</strong>Sodium often moves down its gradient, but it is also involved in secondary active transport to drive uptake of other substances against their gradients (e.g., glucose in intestines).</span><br><span style=\"font-size:12.0pt;\">The Na⁺/glucose symporter (SGLT) is a classic example<strong>.</strong></span><br>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Each substance (oxygen, glucose, calcium, and sodium) has specific and correct transport mechanisms: oxygen by simple diffusion, glucose by facilitated and Na-dependent transport, calcium by active transport, and sodium by secondary active transport.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Dinesh Puri 3<sup>rd</sup> ed/pg-639</strong></span></p>",
      "correct_choice_id": 8380,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}